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INTRODUCTION 
 
 Iron deficiency anemia is considered as one of the most common and 
widespread nutritional disorder in the world. This is a significantly prevalent 
nutrient deficiency disorder in virtually all industrialized nations. This disorder 
also affects a large number of children and women in non-industrialized countries. 
Anemia is more prevalent in south Asia and in India. Up to 88% of pregnant and 
74% of non-pregnant women are affected by this common disorder.(1) 
 
 The prevalence of iron deficiency anemia varies so much between age 
groups, between the sexes, between economic groups  and estimates  suggest that 
as many as three fourths of the world's population is iron deficient(2).WHO 
estimates that about 2 billion people suffer from this disorder. In developed 
countries 8% and in developing countries 36% are affected by this nutritional  
disorder. (WHO 2007) 
 
Either an excess of iron or iron deficiency, the iron status of an individual 
may play an important role in cardiovascular health leading to significant 
problems.(3)Anemia is an independent risk factor for many  adverse cardiovascular 
outcomes  in the general population.(4) 
 
In those people with stable coronary heart disease  it was suggested that 
anemia was associated with low heart rate variability which could increase the 
association of anemia with increased cardiac risk and mortality.(5)Various types of 
heart diseases like cardiomyopathy ,chronic mitral regurgitation, congestive heart 
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failure and myocardial infarction are associated with decreased heart rate 
variability (HRV) which results in increased mortality and morbidity.(6) 
 
Iron deficiency is a condition in which there are no mobilizing iron stores, 
and this causes decreased supply of iron to tissues, including the red blood cells 
.(RBC) It varies greatly with each and every stage of the life cycle in an 
individual. Growing children (up to 2 yrs of age), pregnant, lactating women and 
adolescents   are the most vulnerable groups. 
 
In iron deficiency anemia, hemosiderin and ferritin levels (iron stores) 
decreases to a lower range than normal  and the supply of iron to the transport 
protein which is known as apotransferrin  gets  decreased . This   results in 
reduced transferrin saturation and increase in  transferrin receptors. According to 
WHO haemoglobin less than 12 g/dl of blood  and serum ferritin less than 12 
ng/ml  is considered as iron deficiency anemia. 
 
EPIDEMOLOGY 
 As per studies done by NHANES III (National health and nutrition 
examination survey)  data shows increased prevalence in children and women. 
Adolescent girls, women of child bearing age in the age group of 12- 49 years are 
at increased risk. Womens  with menstrual blood loss  with inadequate dietary 
iron commonly suffer from iron deficiency anemia. Bioavailability of iron also 
influences the daily absorption. 
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 Ligand substances which enhance non heme iron absorption includes 
organic acid like ascorbic acid, citric acid, malic acid and lactic acid. These 
substances are found in citrus and deciduous fruits like peach,  apricot and plums. 
 
 Ligand substances which inhibit absorption includes phytates, polyphenols 
and calcium that  are found in grains and vegetables. Calcium inhibit non heme 
iron absorption. Animal Protein contains increased absorbable heme iron. (103) 
 
HIGH RISK GROUP OF IRON DEFICIENCY ANEMIA 
 Pregnancy 
 Women of reproductive age group 
 Children less than 5 years 
 Adolescents  
 Elderly 
 
 Our study has targeted the population of women belonging to reproductive 
age group. 
 
STAGES IN IRON DEFICIENCY  
FIRST STAGE   
 Storage iron gets depleted and is observed as fall in serum ferritin and this 
reflects presence of low iron in liver, spleen and bone marrow. This is 
demonstrated by the absence of stainable iron in bone marrow during the rapid 
growth period.  
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SECOND STAGE 
 Shows decrease in the transport iron, serum iron, increased total iron 
binding capacity with decrease in transferrin saturation. In both these stages the 
individuals are preanemic and this stage of Iron deficiency is also known as 
“Latent iron deficiency”. 
 
THIRD STAGE 
 There is significant decrease in supply of transport iron which reduces the 
hemoglobin synthesis. Microcytic cells appears which is seen as reduced size and 
is accompanied with decrease in the hemoglobin which makes the cells appear 
hypochromic. 
 
 Iron deficiency anemia develops very gradually and  it takes  months to 
manifest clinically. But the patients laboratory values for serum ferritin and 
transferrin saturation will be within the normal limits and these  patients usually  
respond to the iron therapy well. 
 
CLINICAL FEATURES 
 Significant pallor of both eyelids, dorsum of tongue, nail beds and palms 
(pale palm creases suggest severe anemia) and  glossitis  of tongue are seen. 
Fatigue with low exercise capacity. (mild anemia can produce decreased   
tolerance to exercise) Fissures at the corners of the mouth are seen. Nails show 
pallor, flatness, softness to feel which later becomes spoon shaped (koilonychia) 
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Fig:I pallor of eyelids , palmar creases (A) koilonychia (B) Glossitis of 
tongue(C) 
 
 Children develop irritability and pica for mud and coal substances 
containing lead.(7)Iron deficiency affects mental functions (8) i.e. attention span, 
alertness and learning. 
 
 Iron deficiency in utero causes defects in neurogenesis ,development and 
myelination of neuronal  cells. Moreover  in iron deficiency individuals  there will 
be reduced work performance and decreased effort tolerance.  
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 Since our country people depend   more upon manual labour for their daily 
livelihood, physical impairment due to this nutritional disorder   causes significant 
economic disadvantage for  their families.(103) 
 
 The concentration of serum ferritin will be altered without much  change in 
the total body iron . This however predicts the hepatic iron content to 95% of the 
total load.  serum ferritin value as determined by the ferritin assay will not be 
affected  by recent  supplementation of  iron therapy. But serum iron shows 
variations depending on the iron  therapy .(9) 
 
 Many studies says that anemia when not treated leads to cardiac failure and 
death. (10) Heart rate variability (HRV) is a most commonly used method  to know 
the effects of the autonomic nervous system on the heart and  changes which 
occurs spontaneously in the heart rate. So when heart rate variability decreases  it 
indicates an autonomic dysfunction .Currently, HRV is considered as an important  
predictor tool  to diagnose sudden cardiac  arrest and arrhythmias.(6) 
 
HEART RATE VARIABILITY ANALYSIS 
 Even in the resting state the duration of cardiac cycle of all heart beats 
occurring in one minute, is not at all regular. There is beat to beat variability of 
RR intervals in milliseconds. The beat to beat variation occurring during each 
cardiac cycle is  known as heart rate variability. The RR interval is hence defined 
as the interval of time between the two consecutive heart beats and  is measured in 
millisecond (ms). It  can be measured from Echocardiography.  
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 Heart rate is due to intrinsic activity of sino-atrial node which is the 
pacemaker of heart and has modulating influences on autonomic nervous system 
.Heart rate variability analysis is an analysis of beat to beat variations in heart rate 
and is an important and non- invasive method used to know the integrity and 
autonomic function of heart. The autonomic balance  between sympathetic and 
parasympathetic nervous system of  the heart can be  analyzed by  the variations 
of  RR interval.(11) 
 
 The intrinsic firing rate of un- innervated human SA node is 100 beats per 
minute. If it is innervated, the sympathetic stimulation will cause  increase in  the 
heart rate, while  the parasympathetic stimulation through the vagus nerve will 
cause  decrease in the heart rate. Normally there is predominance of vagal tone 
over the  sympathetic tone which  helps to keep the resting heart rate below 100 
per minute.(12) 
 
 The fact that sympathetic and parasympathetic innervation of SA node 
producing variability in heart rate has been proved by performing a group of tests.  
The heart rate of an individual will be  constantly influenced by external and 
internal stimuli and regulated by the autonomic nervous system. 
 
 Heart rate variability predicts the amount of changes in the length of the 
RR intervals. This can be analysed by a group of tests called as cardiac autonomic 
function tests which can evaluate the functions of  both parasympathetic and 
sympathetic nervous system. These tests assess both the resting and reflex 
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response in heart rate variability to different stimuli. All these tests are performed 
as recommended by Task Force which includes the Resting Heart Rate variability. 
The Resting Heart Rate variability is  sensitive ,specific and is an easy, 
noninvasive tool,  to perform and reproduce.(13) 
 
 An increased HRV indicates the heart’s ability to adapt quickly and more 
flexibly to external and internal influences due to a balanced interplay between the 
sympathetic and parasympathetic nervous systems. A decreased HRV indicates a 
decreased capacity for adaptation  suggesting  impaired autonomic function. 
 
 So in our study HRV analysis is used as a tool to diagnose the imbalance 
between the sympathetic and parasympathetic nervous systems in females  with 
Iron deficiency anemia.  
 
 In our study we have aimed to use Time domain and Frequency domain 
methods of Resting HRV to determine sympathovagal balance. 
 
SERUM FERRITIN 
 There is a direct correlation between amount of  iron stored and serum 
ferritin .Based on this relationship serum ferritin can be used for the diagnosis of 
iron deficiency and also iron overload  .Presence of 1microgram per litre indicates 
8 to 10 mg of storage form of iron (Finch,Huebers 1982) . Normal concentration 
of serum ferritin ranges from 15-300µg/L .Value below 12µg/L indicates that 
there is a lack of storage iron. 
 
 Moreover there is a nonspecific increase in levels of serum ferritin in other 
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inflammatory conditions , neoplastic disorders and liver pathologies. Hence serum 
ferritin is also an acute phase reactant. So,  in our study  patients were selected   
by excluding individuals  who have clinical conditions which could  cause 
elevated serum ferritin level. 
 
 Estimation of serum ferritin is considered  as  the most sensitive and 
specific test for diagnosing  Iron deficiency anemia(IDA) since the level of serum 
ferritin decreases even before the appearance of anemia. This level correlates with 
the body iron stores of the individual. Serum ferritin level less than 12µg/L is 
highly specific for diagnosing IDA.(101) 
 
 Serum ferritin level can be determined by many methods. They  are 
 One site immunoradiometric assay byAddison et al(1974) 
 Two site immunoradiometric assay by Miles et al(1974) 
 ELISA (Enzyme linked immunosorbent assay) 
 Radioimmunoassay(RIA) 
 
 Among these methods Immunoradiometric assay is more sensitive.(102) 
 
 Phlebotomy studies showed that when iron stores were exhausted the levels 
of serum ferritin decreased. Estimation of Hemoglobin, packed cell volume 
(PCV), Mean red cell volume, red blood cell free protoporphyrin were also found 
to be very  useful for diagnosing IDA. 
 
 But the drawback is, these parameters will be abnormal only in the late 
stages of iron  depletion. The reason is due to the increased life span of RBCS. 
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There are many studies available showing the  relationship between iron level , 
heart disease and cancer.(Reddy and clark 2004) 
 
 In our study serum ferritin is used as a marker for diagnosing Iron 
deficiency anemia and aiming to correlate the levels of serum ferritin with the 
HRV parameters. 
 
  
Review of Literature 
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REVIEW OF LITERATURE 
 
 Anemia  is defined  as decreased hemoglobin level in the blood  below the 
normal range in respect of age and sex of the individual.(14) 
 
 The total body iron content is normally about 2.5 gm in women and 6 gm 
in men, and is divided into functional and storage compartments.(15) Most  of  the 
iron available in the diet is in the ferric form but it is the ferrous form that gets 
absorbed from the gastrointestinal tract.(16) 
 
Table-1 Iron Distribution in Healthy normal Young Adults in mg 
Pool Men Women 
Total 3450 2450 
Functional Iron in Pool 2100 1750 
Hemoglobin 300 250 
Myoglobin Enzymes 50 50 
Storage Ferritin pool, hemosiderin 1000 400 
 
 
 About 80% of the functional iron is found in haemoglobin, myoglobin and 
iron containing enzymes such as catalase and  in the cytochromes . The storage 
pool of our body contains hemosiderin and ferritin of about 15% to 20% of total 
body iron. The major sites at which iron gets stored are the liver and mononuclear 
phagocytes. 
 
 Healthy young females have smaller storage form of iron  when compared 
to males  because of blood loss during menstruation, and also due to increased 
demand   of iron during pregnancy. 
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IRON METABOLISM 
 The  absorption of iron occurs in the proximal duodenum. The absorbed  
iron binds to the iron binding glycoprotein transferrin  which is synthesized from 
the liver .The transferrin  delivers iron to erythroid precursor cells present in the  
bone marrow for the synthesis of haemoglobin .The erythroid  precursor cells 
have  receptors that has more affinity for transferrin that helps in incorporation of 
iron into the cell through endocytosis. After the life span of 120 days mature 
RBCS are digested by mononuclear phagocytes present in spleen, liver, bone 
marrow. The iron is separated from the haemoglobin and is recycled back to bind 
with plasma transferrin. 
 
FIG-II Iron Metabolism 
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   Though a regulated pathway for iron excretion is not  clearly understood 
so far, it is assumed that  1to 2 gm of iron is lost due to shedding of skin and 
mucous epithelial cells. 
 
 Therefore any additional iron needed for daily red cell production depends 
on the daily intake   from the diet. Normally, an adult male  needs  at least 1 mg/dl 
of elemental iron daily for normal body system functioning  and this has to be 
absorbed from the daily diet intake .But females in the childbearing years  needs  
an average of 1.4 mg/dl for normal functioning of body systems . But to achieve a 
maximum proliferative erythroid marrow response in conditions like anemia there 
occurs  a markedly stimulated erythropoiesis, where the  demands for iron are 
increased by as much as six- to eight fold.  During these conditions if the delivery 
of iron to the stimulated marrow is not optimum, the marrow's proliferative 
response is diminished which leads to impaired hemoglobin synthesis . This 
diminished response causes hypoproliferative marrow which leads to microcytic, 
hypochromic anemia. 
 
FERRITIN 
 Two proteins present in iron stores that plays major role in Iron metabolism 
are ferritin and hemosiderin . 
 
 Ferritin is a ubiquitous protein-iron complex which is found at highest 
concentration in the liver, spleen, bone marrow, and skeletal muscles. In the liver, 
most of the ferritin is stored within the  hepatic parenchymal cells. In  spleen and 
the bone marrow, ferritin is found mainly in macrophages. The source of iron for 
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ferritin which is present in the hepatocyte is derived from plasma transferrin 
whereas source of iron for ferritin present in the macrophages is derived mainly 
from the breakdown of red blood cells.  Ferritin is stored within the cytoplasm of 
the cells. In  lysosomes of these cells  ferritin is    partially degraded and  clumped 
to form  aggregates  which are called as hemosiderin granules. 
 
 When iron stores in the tissues are normal, only trace amounts of 
hemosiderin will be present in the body and these traces will be seen in 
macrophages of the bone marrow, spleen and liver. When iron stores are 
overloaded  more degradation of ferritin occurs in the lysosomes, therefore the 
amount of hemosiderin increases. 
 
 Since plasma ferritin in circulation is mainly derived from storage pool of 
body iron, the concentration of it seems to correlate well with body iron stores. In 
iron deficiency anemia,  serum ferritin is less than 12microgram per litre ,whereas 
in conditions of iron overload serum ferritin value raises as high as 5000 
microgram per litre.   Physiologically the storage iron will  get  readily mobilized 
from the storage pool whenever there is an increased demand for iron for 
maintaining  the cellular function of the body. 
 
 The iron present in hemosiderin is highly reactive with potassium 
ferrocyanide. Hence Prussian blue staining method by using potassium 
ferrocyanide is used as a special staining method to demonstrate hemosiderin. 
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FIG-III schematic  structure of human Isoferritins 
 
 In the above diagram shaded portions represent the H chains and the plain 
subunits  represent the L chains. The protein shell apoferritin have  24 identical 
subunits which is arranged as 12 dimers and this forms dodecahedron which 
resembles a hollow sphere.  
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NUTRITIONAL IRON BALANCE 
 
 
FIG-IV Relationship between oral iron dosage and iron absorption 
 
 The above figure shows greater  the dose  more is the absorption rate.The 
amount of iron  which is needed  from the diet to replace daily losses averages 
approximately 10% of body iron content  in men and  it averages 15% in women 
of childbearing age. Dietary iron content of the body is closely related to the total 
caloric intake which is assumed to be approximately 6 mg of elemental iron per 
1000 calories. Iron bioavailability is also affected by the nature of the foodstuff 
taken .The heme iron (e.g., red meat) being most readily absorbed.  Vegetarians 
have an additional disadvantage because certain foodstuffs that include phytates 
and phosphates reduce the absorption of iron by approximately 50%. When iron 
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salts in the ionized form is taken along with the food the amount of iron absorbed 
by the intestine gets reduced. 
 
 The balance of iron in humans is tightly controlled and designed in such a 
way to conserve iron to the maximum possible rate for reutilization. Iron is lost 
from body, by the loss of epithelial cells from the skin, gut, and genitourinary 
tract.  The  route by which iron enters into the body is   from food, oral intake of 
medicinal iron ,  red-cell transfusions or injection of iron complexes. The margin 
between the amount of iron which is available for absorption and which is 
required for iron in growing infants and  adult female population is narrow. This 
accounts for the greater prevalence of iron deficiency worldwide in these 
vulnerable groups .Currently it is estimated around one-half billion people to be 
affected by Iron deficiency anemia. 
 
 Therefore in our study most vulnerable female population are chosen and it 
could form a basis to identify and to prevent the clinical consequences at the 
earliest time. 
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REGULATION OF IRON ABSORPTION 
 
FIG-V Regulation of iron absorption 
 
 Absorption of iron takes place largely in the proximal small intestine and 
this absorption is a carefully regulated process. Iron is absorbed by the luminal 
cells present in the small intestine. This process of absorption is facilitated by the 
acidic contents of the stomach, which is essential to maintain the iron in solution.  
The ferric iron is converted to the ferrous form by an enzyme ferrireductase at the 
brush border of the cell. This is then transported across the membrane by divalent 
metal transporter type 1 [DMT-1, which is  also known as natural resistance 
macrophage-associated protein type 2 (Nramp 2) or  DCT-1(Divalent  cation 
transporter).  After entering the gut cell, iron may be stored as ferritin or it is 
transported through the cell and gets released at the basolateral surface to bind 
with plasma transferrin through the membrane-embedded iron exporter, 
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ferroportin. During the process of release, iron binds with  oxidase known as 
hephaestin, which oxidizes the iron to the ferric form. 
 
 Hepcidin, the principal iron regulatory hormone regulates the function of 
ferroportin by negative feedback mechanism. Hepcidin is a small circulating 
peptide which is produced and released from the liver .When body storage iron is 
adequate hepcidin level increases and binds to the ferroportin and causes 
degradation by endocytosis of the receptor. This leads to down regulation of 
ferroportin present on basolateral surface of the cell membrane .Hence iron gets 
trapped within duodenal cells in the form of mucosal ferritin and will be lost 
during sloughing process of the cells. 
 
 Conversely when the storage iron is less, the level of hepcidin falls which 
leads to increased ferroportin activity. Then the absorbed iron is transferred to the 
plasma transferrin. 
 
 Iron absorption is influenced by various states of normal physiological 
mechanisms . Erythroid hyperplasia stimulates the absorption.   Thus, in patients 
with anemia absorption rate is more  due to stimulated erythropoiesis.  
 
 When iron stores are depleted, the serum iron concentration begins to fall. 
Gradually, the TIBC and the red cell protoporphyrin levels are increased. By 
definition, marrow iron stores are absent when the serum ferritin level goes below 
15 micro gram/L. Hemoglobin synthesis is unaffected till the serum iron remains 
within the normal range despite the changes in iron stores.  But decrease in the 
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level of transferrin saturation  below 15–20%,will affect hemoglobin synthesis. 
This is  known as iron-deficient erythropoiesis. 
 
 Examination  of the peripheral blood smear shows   microcytic red blood  
cells.  The hemoglobin and hematocrit begins  to fall indicating  iron-deficiency 
anemia.  
 
 In cases of moderate anemia (hemoglobin 10–13 g/dL), the bone marrow 
shows hypoproliferative response. In  severe cases of  anemia (hemoglobin 7–8 
g/dL)peripheral smear shows characteristic feature of microcytic hypochromic 
RBCS .  Target cells and abnormal shapes of red cells (Poikilocytes) appear on 
the blood smear . Some abnormal shapes seen are cigar- or pencil-shaped forms. 
 
 The bone marrow picture shows ineffective erythropoiesis. Consequently, 
with severe prolonged iron-deficiency anemia there occurs  erythroid hyperplasia  
rather than the hypoproliferative response. 
 
Evaluation of Bone Marrow Iron Stores 
 Reticulo endothelial cell iron stores can be estimated by doing special 
stains for iron on bone marrow aspirates or by bone marrow biopsy.  Because of 
convenience the measurement of serum ferritin  is used as a marker of Iron 
deficiency anemia. The serum ferritin level is a better indicator  than the marrow 
iron stain. But, in addition to storage iron, picture of the marrow iron stain  gives 
valuable  information about the  delivery of iron to the developing erythroblasts. 
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Table -2  Measurements of  Marrow iron stain , Serum ferritin assay and 
Normal values of iron stores. 
Marrow Iron by Stain, 
0-4+ 
Serum Ferritin by 
assay, g/L 
Normal range of 
Iron Stores(mg) 
0 
Trace to 1+ 
2+ 
3+ 
4+ 
<15 
15–30 
30–60 
60–150 
>150 
0 
1–300 mg 
300–800 mg 
800–1000 mg 
1–2 g 
 
IRON DEFICIENCY ANEMIA 
ETIOLOGY. Iron deficiency anemia  can result from 
1) Dietary lack 
2) Impaired absorption 
3) Increased requirement 
4) Chronic blood loss 
 
CAUSES OF IRON DEFICIENCY ANEMIA 
 Conditions that increase the demand for iron, increased iron loss or 
decreased iron intake or absorption can produce iron deficiency anemia and is 
broadly classified as follows 
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Table-3  Causes of Iron Deficiency anemia  
Demand for Iron  increases during 
 Growth spurt in infancy or adolescence 
 Pregnant womens 
 Erythropoietin hormone therapy 
Increased   Loss of iron 
 Chronic blood loss 
 Menstruation 
 Acute blood loss during Blood donation 
Decreased  Intake of iron or decreased Absorption 
 Inadequate diet intake 
 Malabsorption due to gastrointestinal disorders  celiac sprue, Crohn's 
disease) 
 Malabsorption  due to  gastrointestinal surgery (postgastrectomy patients) 
 Acute or chronic inflammatory conditions 
 
 The bioavailability of dietary iron is very much important as it influences 
the over all body iron content. Heme iron is  the absorbable form of iron than 
inorganic iron, and its absorption  is influenced by other dietary contents. Iron 
absorption is enhanced by ascorbic acid, citric acid, amino acids, and sugars in the 
diet, and absorption is inhibited by tannates  (found in tea),carbonates, oxalates, 
and phosphates. 
 
  Anemia due to dietary lack is rare in developed countries, but the situation 
is different in developing countries like India, where there is poverty and most 
dietary iron is found in plants in the poorly absorbable inorganic form. Inadequate 
iron in the diet  is also seen in privileged societies in the following groups: 
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 Infants  are at high risk due to the very small availability of iron in 
milk. Human breast milk provides only about 0.3 mg/L of iron 
which is very minimal in amount.  However Cow’s milk contains 
about twice as much iron, but its bioavailability is poor. 
 
 Older adults, who often have restricted diets with less intake of meat 
because of limited income or poor dentition. 
 
 Teenagers who are attracted more toward the  “junk” food. 
 
  Decreased  absorption of iron is seen in malabsorption disorders like  
sprue,  steatorrhea  and in cases suffering from chronic diarrhea. 
 
 Gastrectomy also impairs iron absorption by decreasing the acidity of the 
proximal duodenum. 
 
 Increased requirement is an important cause of iron deficiency in growing 
infants, children,  adolescents and in pregnancy.   
 
 Economically deprived women  belonging to low  socioeconomic group   
having multiple, closely spaced pregnancies are at increased  risk. 
 
      Chronic blood loss is  one the most common cause of iron deficiency in the 
Western world. External haemorrhage,  bleeding into the gastrointestinal tract, 
urinary and  genital tracts decreases the iron reserves of the body. 
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FIG-VI Relation between serum ferritin in normal and iron deficiency 
individuals 
 
 The Figure shows depletion of storage iron in iron deficiency anemic cases 
when compared to normal individuals. 
 
Pathogenesis of iron deficiency anemia 
 Whatever is the etiology, iron deficiency produces a hypochromic 
microcytic anemia. Progressive depletion of iron stores first lowers serum iron 
and transferrin saturation levels without producing clinical symptoms of anemia . 
In this early stage of depletion of iron stores, the bone marrow shows increased 
erythroid activity and the clinical symptoms of  anemia appears only when  the 
storage iron gets completely depleted along with reduced serum iron, ferritin and 
transferrin saturation levels.  
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MORPHOLOGY 
1. BONE MARROW STUDY 
 Bone marrow study reveals  a mild to moderate increase in the precursors 
of  erythroid  series. Staining of bone marrow aspirates by  Prussian blue stains  
shows absence of stainable iron in the macrophages  within the marrow and this is 
considered as a  very important diagnostic finding. 
 
2. PERIPHERAL BLOOD SMEAR STUDY 
 
FIG-VII  peripheral smear with normocytic and normochromic RBCS 
 Normal red cells with adequate hemoglobin have a zone of central pallor 
which occupy about one third of the cell diameter. 
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FIG-VIII Peripheral smear with microcytic hypochromic RBCS 
 
 The red  blood cells appear  small in size(microcytic) and shows increased 
pallor (hypochromic).In iron deficiency anemia  the zone of pallor is increased  
and the pink hemoglobinisation is seen only in a narrow peripheral rim of the 
RBC . Poikilocytosis in the form of small, elongated red cells known as pencil 
shaped cells are seen. 
 
FIG-IX Peripheral smear  of  iron deficiency  anemia with anisocytosis and 
poikilocytosis 
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DIFFERENTIAL DIAGNOSIS 
 Iron deficiency anemia  has to be differentiated from  anemia  of chronic 
inflammation, thalassemia and sideroblastic anemia.  Differentiation  between true 
iron-deficiency anemia and the anemia associated with chronic inflammation is 
the most common  problem faced by clinicians in the routine practice . The 
anemia of chronic inflammation is normocytic and normochromic. The iron 
studies  usually make the differential diagnosis clear, as the ferritin level is normal 
or increased and the  transferrin saturation , total iron binding capacity( TIBC) are  
below the normal range. 
 
 Laboratory iron studies helps to distinguish these conditions.   
 
Table- 4  Differential Diagnosis of Microcytic Anemia 
Laboratory 
Tests 
Iron 
Deficiency 
anemia 
Anemia in chronic 
inflammation Thalassemia 
Sideroblastic 
Anemia 
Peripheral 
smear 
Microcytic 
and 
hypochromic 
Normal 
microcytic/hypochromic 
Micro/hypo 
with target 
cells 
Variable 
Serum  iron <30 <50 Normal to high 
Normal to 
high 
Total iron 
binding 
capacity 
>360 <300 Normal Normal 
Transferrin 
saturation <10 10–20 30–80 30–80 
Serum Ferritin 
(µg/L) <15 30–200 50–300 50–300 
Hemoglobin 
pattern on 
electrophoresis 
Normal Normal Abnormal  Normal 
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Treatment: Iron-Deficiency Anemia 
 
 The severity and cause of iron-deficiency anemia  determines the mode of 
treatment. Symptomatic elderly patients with severe iron-deficiency anemia and 
cardiovascular instability  requires the treatment by red cell transfusions. Younger 
individuals who have compensated for their anemia can be treated by   
conservative management with iron replacement. It is important to identify   the 
etiology of iron deficiency anemia before iron therapy. 
 
 Once the diagnosis of iron-deficiency anemia and its cause is made out,  
three major therapeutic approaches can be targeted.(88) 
 
Oral Iron Therapy 
 Oral therapy  is preferable since it is safe and also cheaper  than  parenteral 
therapy. Ferrous sulphate is the preferred  preparation. one tablet of ferrous 
sulphate(200mg) contains 60 mg of elemental iron .The usual dose is 1 tablet 
thrice daily. 
 
 Following  treatment  reticulocytosis  develops within 3 to 7 days and 
peaks between  8 to 10 days. This is followed by gradual increase in haemoglobin. 
It takes around  6 to 8 weeks for restoration of haemoglobin level. Treatment is 
continued for further 4 months in order to replace body iron stores. 
 
 Adverse effects are vomiting, constipation , diarrhoea and abdominal pain. 
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Parenteral Iron Therapy 
This  includes  
 Iron dextran (IM/IV) 
 Iron sorbitol citrate(IM) 
 Parenteral iron is usually given intramuscularly into the buttocks by Z track 
technique to prevent staining of the skin. 
 
 Hypersensitivity test prior to parenteral iron is necessary in order to avoid 
anaphylactic reactions. 
Blood transfusion 
Packed red cell transfusion is preferred. 
 
AUTONOMIC NERVOUS SYSTEM 
 The relationship between anemia and heart rate variability had  been  
analysed and studied  in several types of anemia like thalassemia, Vitamin B12 
deficiency , megaloblastic anemia(17) sickle cell trait(18). However, so far  there are 
only few datas  available  regarding  autonomic functions in patients with iron 
deficiency anemia,  which is one of the leading cause for anemia in the general 
population.(19) 
 
 Yokusoglu et al(20) reported that   HRV indices when analysed,  were 
impaired and this impairment was due to increased sympathetic or decreased 
parasympathetic activity in iron deficiency anemia. It is reported that 
supplementation of  iron  therapy is effective and beneficial in improving the 
dysregulation caused by the alteration of autonomic nervous system reflexes.(21) 
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It was reported that HRV parameters were decreased in patients diagnosed of   
vitamin B12 deficiency. But this decrease in sympathetic HRV parameters was 
comparatively more than those measured in parasympathetic HRV parameters.(19) 
 
 But on contrary to these observations  regarding HRV parameters  some 
investigators observed that  there was no significant difference between the 
healthy group and iron deficient anemic patients.(21,22) 
 
 Therefore, this study has been designed to assess the cardiac autonomic 
nerve function by analyzing the HRV parameters in adult female population in the 
reproductive age group with iron deficiency anemia. 
 
 Iron metabolism is very important for energy production in the tissues of 
our body and it is utmost important  for the cells which  needs high energy  for 
their effective function such as cardiomyocytes.(23) Iron plays an important  role in 
oxygen transportation (as a component of Hb), and also in  oxygen storage. (as a 
component of myoglobin). 
 
 Iron also plays crucial role in oxidative metabolism as a component of 
oxidative enzymes in Respiratory chain processes   and in metabolism of lipids 
and carbohydrates .[24, 25] Iron deficiency either  due to  absolute or functional 
deficiency can impair oxidative metabolism, cellular energy, and  the immune 
mechanism of the  red blood cells. 
 
 Experiments were done in Iron deficiency rats  and hearts  of these animal 
model showed aberrations in the ultrastructure of mitochondria. Sarcomere 
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organization was found to be irregular, and release of cytochrome C was seen.[26]. 
 
 In these animal models it was found that, in animals with severe iron 
deficiency there was alterations in energy production and this  caused extensive 
cardiac damage, associated with diastolic dysfunction of the heart .These changes 
progressed  to heart failure, and it was found that there was  reduced levels of  
erythropoietin( EPO) and  this was associated with increased levels of   tumour 
necrosis factor alpha(TNF-α ) in  serum  and this lead to the worsening  of 
molecular signalling pathways. And  these over all  defects ended  with the 
transition from adaptive cardiac hypertrophy to permanent cardiac impairment in 
chronic iron deficiency anemia worsening the   health status of the individual.[27] 
 
 On the other hand, iron  also plays a  role in mediating the anti-
inflammatory effects  in the body. Furthermore studies showed that in iron 
deficiency anemia there was increased  red cell oxidative stress [28] and there was 
less oxygen consumption and increased rate of ventilation which lead to increased 
carbon dioxide production . In a recent study the irregulated iron homeostasis has 
been identified as one of the independent risk factor for morbidity and 
mortality.[29] 
 
 Another devasting effect of iron deficiency on CHF patients is the 
consequence of developing thrombocytosis which might be a reactive one. CHF 
results in a hypercoagulable state[30] in which iron deficiency related 
thrombocytosis occurs[31] and this increases the risk of thrombosis in the vessels 
and increases the mortality rate.[32] 
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 Autonomic nervous system (ANS) which is a part of the nervous system 
was introduced by Langley in 1898 and this system plays a very important  and 
responsible role in maintaining the homeostasis and also innervates all organs 
except the skeletal muscle which is supplied by the somatic motor system.  
 
 The two important  major divisions of ANS are the sympathetic  nervous 
system also known as thoracolumbar division due to the location of the ganglia 
and cell bodies of the neurons at the thoracic and lumbar segments of the spinal 
cord and the other division is the parasympathetic nervous system also known as 
craniosacral division the cell bodies of which are located in the  brain stem cranial 
nerve nuclei and spinal cord. The two divisions work together  both reciprocally 
and synergistically in a coordinated manner to maintain the body homeostasis. 
The enteric nervous system which acts as a local neural circuitry in the GIT forms 
the third division of  ANS. 
 
 The preganglionic and post ganglionic neurons forms the peripheral motor 
part  of the autonomic nervous system. The axons of preganglionic neuron are 
small, myelinated ,slow conducting B fibers  projecting to eight or nine 
postganglionic neurons. This results in  a diffuse autonomic output, whereas  the 
postganglionic neurons belong to the category of unmyelinated C fibers  that 
terminate on the visceral effector organ.(33)The ratio of preganglionic to 
postganglionic neurons in parasympathetic system is smaller and is seen in the 
ratio of (1:15 to 1:20) in contrast to the sympathetic nervous system.  
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 This smaller ratio between pre and post ganglionic neurons of 
parasympathetic system  helps in more localized and specified  effect . In contrast, 
the increased ratio(1:100) of preganglionic and postganglionic neurons  in the 
sympathetic nervous system  presents with wide spread sympathetic autonomic 
effects and increased  sympathetic outflow especially during  strenuous physical 
activity and  stressful environments. 
 
 Parasympathetic and sympathetic divisions of ANS differs anatomically, 
morphologically, physiologically and pharmacologically in many aspects. Though 
they operate in a reciprocal and antagonistic manner their actions are highly 
controlled and integrated  by the higher centres. 
 
 Sympathetic activation causes the individuals to mobilize and spend the 
energy and  hence it is a system of energy utilization . In contrast parasympathetic 
activation causes conservation of energy and hence this is a system  of energy 
saving. 
 
NEUROTRANSMITTERS IN ANS  
 The principal neuro transmitter agents involved are acetylcholine released 
from the parasympathetic nerve endings and norepinephrine  released from  the 
sympathetic nerve endings. The evidence for this concept of  chemical 
neurotransmission was experimented and studied  by Otto Loewi in 1920 .The 
chemical released by vagus nerve was named as vagusstoff by Loewi,  which was 
later chemically identified as acetylcholine.(17) 
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FIG-X Comparison  of autonomic nervous system  and somatic nervous 
system 
 
AUTONOMIC INNERVATION OF HEART  
 The Cardiovascular system are innervated by both sympathetic and 
parasympathetic  divisions of ANS. This is controlled by cardiac vascular centers 
situated in the medulla, which form the integrators of cardiac autonomic reflex. 
The sympathetic innervations is controlled by Rostral Ventral Lateral Medulla 
(RVLM)   which is a  cardiac  excitatory area. This excitatory centre located  in 
the medulla is also known as vasomotor center.  
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 This projects to the intermediolateral horn of the spinal cord through the 
bulbospinal pathway from where the sympathetic fibers takes its origin. The 
cervical sympathetic nerves forms the efferent pathway of cardiac autonomic 
reflex. The parasympathetic center is located in dorsal motor nucleus of vagus and 
nucleus ambiguous in the medulla and its efferent is the vagus efferent nerve.  
 
 The afferent inputs from various peripheral and central organs reach these 
cardiac autonomic centers via the afferent pathways. Some inputs stimulate the 
cardiac inhibitory centers, which in turn inhibits the accelarator center.  
Depending on the stimuli there will be an increase or decrease in the nerve traffic 
impulse and this   produces response by acting on the target organs. 
 
Distribution of autonomic receptors in heart  
 1. Acetylcholine Receptors: These receptors have been divided into two 
types based upon their pharmacologic properties. They are Muscarinic  receptors 
and Nicotinic cholinergic receptors. Muscarinic type of cholinergic receptors is 
found in heart tissues and  mainly belongs to  M2 subtype. It is a serpentine type 
of  G protein  coupled receptor  which acts via heterotrimeric G proteins  and 
activates  adenylyl cyclase. Here the second messenger involved  by activation of 
this receptor mechanism is the cyclic AMP. 
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FIG -XI. Autonomic Innervation of Heart 
 
 2. Adrenergic receptors: The adrenergic receptors are of two types. The 
neurotransmitter released  from the postganglionic sympathetic neurons are 
norepinephrine  which acts through adrenergic receptors. 
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 The adrenergic receptors are G protein coupled receptors. Two major types 
of adrenergic receptors are Alpha(α)   receptors  and Beta,( β) receptors,  and there 
are multiple subtypes (e.g., α1, α2, β1, β2 and β3). These receptors act by 
stimulating the intracellular signal transduction pathways , acts on membrane 
channels and causes increased production of cyclic AMP . The β1 receptors in the 
heart activate the G stimulatory protein(Gs) and stimulate the enzyme adenylyl 
cyclase, which blocks  the effects of muscarinic receptors .These receptor 
subtypes have a tissue-specific distribution in our body. α1 receptors are present  
on the blood vessels, α2  are present on presynaptic terminals, β1 is present in the 
heart, β2 is present  in the bronchial muscle of the lungs and β3 in fat cells.  
 
STIMULATION OF HEART BY VAGUS:  
 The stimulation of vagus causes release of the neurotransmitter 
acetylcholine which acts on  the muscarinic receptors. This causes increase in the  
permeability of the nerve cell with resultant opening of K+  channels. This  causes 
hyperpolarization by increasing the negativity inside the cells and makes the  
tissue less excitable. The opening of the Ca+ channels also slows down. This 
hyperpolarization will  cause resultant decrease in the resting membrane potential 
of the sinus nodal fibers  and changes the potential more negative from -65 to -75 
mv than the  normal level of -55 to -60 mv. So  the fiber takes a very  longer time 
to reach the threshold potential to get excited. Therefore stimulation of vagus  
decreases the rate of impulse generation. The response  of the heart to sympathetic 
stimulation starts rapidly and gets  dispersed slowly. But the  response of the heart 
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to vagal stimulation begins  slowly and disappears fastly. This type of response 
due to the vagal stimulation causes rapid and dynamic beat to beat variation in 
heart rate and AV conduction in the conducting system of the heart but in contrast  
the response of sympathetic stimulation occurs slowly and  is  a temporary one. 
 
 Arrival of a systolic pressure wave  at the baroreceptor sites in the walls of 
the carotid and aortic sinus regions causes  periodic vagal bursting discharge from 
vagal efferent . The response is the  change in the duration of cardiac cycle length 
in a phasic manner which causes the sinus node to discharge at a variable  rate 
known as  the vagal burst. And this burst activity prolongs AV nodal conduction 
time and in addition this   is influenced by sympathetic tone. Whenever  there is  a 
brief vagal burst, it decreases the SA node rate without altering the AV 
conduction time  orelse it can cause prolongation of the AV node conduction time. 
But this will not influence  the sinus node rate. The underlying reason behind this 
is in a cardiac cycle the peak vagal effects can occur at different times. This shows 
that vagus can have both direct and indirect effect causing response in the target 
structures.(12) 
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FigXII:Baroreceptor reflex 
 
 STIMULATION OF HEART BY SYMPATHETIC SYSTEM:  
 The neurotransmitter noradrenaline is released from the sympathetic fibre 
endings during stimulation of the sympathetic nerve.   This  acts on beta1 
receptors and causes rapid opening of Ca+ channels. This  causes  depolarization 
potential and  the prepotential slopes which increases the heart rate. The 
stimulation of right stellate ganglion causes increase in the rate of impulse 
formation in the SA node. The stimulation of left stellate ganglion increases the 
rate of conduction in the  AV node.  
 
 Inhibiting the enzyme adenylyl cyclase via inhibitory G protein(Gi)will 
block  the adrenergic effects on the sinus node. 
 
 At the end of vagal stimulation, the rate of discharge from the sinus node 
may accelerate which results in post vagal tachycardia.(34) 
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CONTROL OF AUTONOMIC FUNCTION BY HGHER CENTERS:  
 The insular and medial prefrontal areas  of cerebral cortex are the sensory 
and motor areas which controls autonomic function. 
 
Hypothalamus, brainstem, limbic system are the higher centers which integrates 
and regulates the visceral functions and maintains the homeostasis.  
Hypothalamus is known as the  “Head ganglion of the ANS” named by  Charles 
sherrington  in the year 1906. 
 
 The autonomic components of emotional responses are controlled by 
amygdala in the temporal cortex.  Diencephalon, brainstem and  the spinal cord 
that are involved in the control of autonomic functions are known as the central 
autonomic network. 
 
HEART RATE VARIABILITY IN IRON DEFICIENCY ANEMIA 
 There are studies done in IDA  patients in which some studies showed 
alterations  in the HRV parameters and some studies showed only the  basal 
changes. 
 
 Yokusoglu et al   in his study demonstrated  that there were alteration in 
autonomic balance  in patients with iron deficiency anemia. In his study he 
observed there was no significant differences in relation to age and gender when 
he compared the case group and control group. He observed mean heart rate was 
increased and hemoglobin , PCV  and ferritin  values were lower in the case 
group. The parasympathetic activity parameters like RMSSD, PNN50  were found 
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to be decreased in the case group which states that parasympathetic activity is 
reduced and sympathetic activity is predominant in patients with IDA .(22) 
 
 Farhana rahman et al observed in his study that the mean values of R-R 
interval was decreased in anemic subjects  and mean values of heart rate was 
higher in anemic patients. He observed that the mean SDNN and RMSSD were  
lower in the anemic group indicating reduced parasympathetic activity.(35) 
 
 Tuncer et al observed in his study that only the mean heart rate was 
increased and he demonstrated in his study that there was no significant difference 
between the control and the case group related to HRV parameters.(21) 
 
 Lufti et  al observed in his study that frequency domain measures was 
significantly correlated with haemoglobin concentration. He observed that 
increase in the haemoglobin concentration of the individuals  showed increase in 
the TP,VLF,LF,HF  bands of power spectral analysis of HRV.(36) 
 
 Ayetmir et al did observational study in megaloblastic anemia and he 
reported that LF,LF Norm, HF,HF Norm ,LF/HF ratio was reduced.(19) 
 
 Veglio et al observed that the sympathetic activity was reduced in 
thalassemia  in majority of  individuals presenting with anemia.(37) 
 
 Gehli et al observed in his study that decrease in one gram of haemoglobin 
resulted in a decrease in HRV parameters.(5) 
 
 Lakholia et al  observed in his case group that  there was a decrease in the 
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basal parasympathetic HRV parameters and this was to increase the heart rate as a 
compensatory mechanism.(38) 
 
 Anirrudha et al observed in his study  that basal heart rate was increased 
and he observed decrease  in the systolic and diastolic pressure due to decrease in 
the peripheral resistance in anemia. The valsalva maneuver  done for the iron 
deficiency anemic patients showed lower values when compared with the 
control.(39) 
 
 Nithyanand et al observed in his study that  basal heart rate was decreased 
in patients suffering  from chronic severe anemia due to abnormal dysfunction of 
afferent pathway and he observed abnormal valsalva ratio in  iron deficiency 
anemia individuals.(40) 
 
 Glick et al in 1964 performed experimental study in unanesthesized dog 
with  induced anemia and observed increase in the heart rate.(41) 
 
HEART RATE VARIABILITY 
  Heart rate variability is beat to beat variation in heart rate  under resting 
conditions. These beat to beat variations occur due to continuous changes in the 
sympathetic and parasympathetic outflow to the heart. It is the oscillations in the 
RR interval between two consecutive heart beats. The rhythm of the heart is 
controlled by the sinoatrial  node, which is modulated by both the sympathetic and 
parasympathetic branches  of the autonomic nervous system.   
 
 These variations in the heart beat was found to vary during the different 
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phases of  the respiratory cycle and hence  it is also known as Respiratory Sinus 
Arrythmia. (RSA) 
 
 Though literature gives many explanation for  the physiological basis of   
HRV the view regarding this still remains controversial .  Traube et al (1865) 
explained that the medullary centres controlled the activity of the heart  and 
caused changes in   the arterial pressure waves. Karl Eward Hering (1871) 
concluded   that it was a reflex mechanism which caused  activation of the 
afferent fibres innervating  the lungs  that resulted in the periodic changes in the 
respiratory cycle. 
 
 Bainbridge (1930) proposed that the changes were not due to neural 
involvement and found the variability is due to intrathoracic pressure changes 
which caused mechanical distortion of atria during the different phases of  
respiratory cycle . Franciscus C. Donders (1868)   suggested  that it is the vagal 
activity  that produced  changes in heart rate during different  phases of 
respiratory cycle. Guyton and Hall (1951) also  explained  the autonomic activity 
by performing experiments in animals. All these  studies were  experimented in 
mammals like dogs, cats and also in humans. 
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 For diagnosing diabetic neuropathy simple test for R-R difference was 
introduced by Ewing et al.(80) 
 
 Higher HRV reflects that there is good balance between the sympathetic 
and the parasympathetic nervous system of our body.  
 
 Decreased HRV reflects  alteration in autonomic function and disturbance 
in   homeostasis. This indicates impairment in adjustment of body functions and 
ends up in health consequences.(Sampler MB et al, Lele AS et al, 1980) 
 
 Today it is widely accepted that HRV is due to the fluctuations of the 
vasoconstrictor and vasodilator cardiovascular centres  in the medulla. 
 
 
FIG-XIII Cardiovascular centres in brain 
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 Stimulation of sympathetic nerves in the heart causes release of 
epinephrine and norepinephrine and stimulation of vagus in the heart causes 
release of acetylcholine as neurotransmitter.(42)Heart rate variability is the 
routinely used term used to describe variations in heart rate and R-R interval . 
There are other terms which are also used to describe this variability such as  
cycle length variability, heart period variability, R-R interval tachogram, R-R 
variability. 
 
 The fluctuations are  due to baroreflex mechanism which is influenced by 
the variations in blood pressure, respiration, temperature and circadian rhythm. 
All these parameters fluctuates and affects the length of RR interval. This  
explains that this interval is between two successive heart beats and not the heart 
rate.  
 
 The sympathetic and parasympathetic system have antagonist actions and 
acts in a balanced manner  to achieve optimum  response  and  maintain the 
homeostasis of our body. Thus  HRV reflects the sympathetic and 
parasympathetic balance in the body at any point of time.(43) When  HRV 
parameters are increased it indicates a quicker  normal response to various 
influences and decreased HRV indicates there is autonomic dysfunction leading to 
health impairment.(44) 
 
 This decrease in HRV parameters  is an alarming signal indicating 
impairment in homeostatic mechanisms. 
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 Heart rate variability (HRV)  measures  respiratory sinus arrhythmia during 
which the heart rate increase  during inspiration, and decreases during expiration, 
in which the R-R interval  shortens during inspiration and prolongs during 
expiration when recorded by ECG. This is a normal phenomenon, which  
decreases with increasing age and also during stressful conditions.  
 
 Animal studies have shown that HRV  reflects vagal activity.(45) Bernston 
et al performed experiments in humans by blocking parasympathetic system by 
drug atropine and this study reflects  HRV is a function of parasympathetic 
activity.(46) 
 
 The clinical based study was done which showed  that fetal distress was 
preceded by alterations in inter beat intervals before there were significant 
changes  in heart rate itself.(47) There  are many simple bedside tests for evaluating  
short-term HRV.(48)  
 
 Wolf et al  in his study observed there was an  increased risk of  post 
infarction mortality when HRV is decreased  and hence HRV has a role  as non 
invasive tool for diagnosing heart disease .(49) 
 
 Stein P.K. et al (1994) proposed that the activity of autonomic  innervation 
on sinus node of heart can be measured using heart rate variability as it is a non-
invasive  tool.(50) Akselrod et al 1981 introduced power spectral analysis of 
fluctuations seen during heart beat.(51) 
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 Juan Sztajzel et al, 2004 stated in his study  that to evaluate autonomic 
imbalance and to know the functional integrity, resting HRV can be used.(52) 
 
 Thus, Donald Moss and Fred Shaffer aptly described that “The human 
heart is a bio-electrical pump, beating at an ever changing rate; it is not like a 
clock that beats at a steady unchanging rate.”  
 
 Over a decade of 40 years various studies was conducted  that  showed the 
relationship  and influence of autonomic nervous system activity (ANS) on 
cardiovascular system and also the consequences leading to sudden death in 
cardiac arrhythmias.(12) 
 
COMPONENTS OF HEART RATE VARIABILITY:  
 Vagal and sympathetic activity   interacts with each other and during the 
resting state it is the vagal tone that predominates .This activity is highly 
influenced by cardioinhibitory  and cardiostimulatory centre located in the 
dorsolateral and ventrolateral medulla. Stimulation of afferent vagus  causes  
parasympathetic activity and   via efferent vagus innervating heart it  also causes 
reflex inhibition of sympathetic activity.  
 
 Stimulation of afferent sympathetic and inhibition of parasympathetic 
activity occurs by a opposite reflex mechanism .  Efferent sympathetic and vagal 
activity influences the sinus node and causes discharge from it, this occurs  with 
each and every cardiac cycle which is then modulated by vasomotor and 
respiratory center and also  by arterial pressure and respiratory   movement 
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oscillators known as peripheral oscillators. 
 
 These oscillators  depending on the external or internal influences 
generates rhythmic fluctuations in efferent neural pathway that manifest as short 
and long term oscillations in the heart rate.(6)  Analyzing the pattern of  rhythm 
gives  us the idea about the 
1) Sinus node activity 
2) Sympathovagal activity 
3) Central oscillators  
4) Humoral factor  
 
CLINICAL USES OF HRV:  
 HRV is an easy, non‐invasive , nonexpensive tool  for measuring both 
cardiovascular and non-cardiovascular autonomic function.  
 To evaluate the effectiveness of the therapy and to know the prognosis. 
 HRV is used  in sports physiology for exercise training and athelete 
performance. 
 To assess the outcome of stress relaxation programs like massage, exercise, 
meditation, yoga. 
 HRV analysis is an important  predictor of risk complications   after MI 
and  arrhythmias. 
 HRV can also be used to find out autonomic dysfunction in diabetes 
mellitus and rheumatoid arthritis patients. 
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There are two types of  assessment for heart rate variability.(53) 
1. Time domain methods –  By using statistical methods on RR intervals 
various indices were calculated. 
2. Frequency domain methods– Indices  were calculated by spectral 
analysis of RR intervals. Assessing  the accurate timing of R waves is must 
in both of these methods. The analysis can be done  on short term ECG 
segments  lasting for 5 minutes or on  ECG recordings taken for 24 hrs.   
By this short-term variability (STV) indices rapid  changes in heart  rate  
can be recorded. 
 
Power Spectrum Analysis of HRV 
Power spectrum of HRV can be analyzed by two methods: 
1) Fast-Fourier transform  analysis 
2) Autoregressive modelling analysis 
 
Fast Fourier Transform 
 Any electrophysiological signal arrived is  the  sum of sine waves and this  
signal after the process of  decomposition is called the Fast Fourier 
Transform.(FFT) An efficient algorithm was carried out for this transformation 
and this is known as the FFT. This was modified with few improvements .This is 
used  in  many  clinical applications, such as voice analysis or vibration studies. 
 
1. The analysis of short-term HRV (SHRV) is  the one which comes under 
these applications. 
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2. FFT algorithms have its own draw back since this requires  an evenly 
sampled, infinite and stationary time series  for analysis. 
 
Autoregressive Modeling 
 This is   an alternative method to the FFT   .This is combined with power 
spectral estimation for the assessment of SHRV. This method fits the data to a 
prior defined model and by this, parameters are estimated  . The power spectrum 
parameters are then computed. 
 
 FFT or AR modeling methods have a common goal which means the 
estimation of the power spectrum of a signal follows the same principle. 
 
 FFT-based methods are also known as nonparametric methods  since the 
time domain prior to spectral analysis  is greatly simplified. 
 
 AR methods are parametric since they require prior information of the 
system under study. 
 
 Thus, it was suggested that FFT-based methods are still the best and 
Commonly  used one. (81) 
 
  The Fast Fourier Transform and Autoregressive algorithms are the 
most commonly used tools in clinical and research programmes to study the 
SHRV. 
 
 In HRV analysis  the heart rate as a function of time or the intervals 
between two successive QRS complexes has to be determined.  Here the term 
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HRV means the variability of RR intervals (i.e. intervals between the consecutive 
R peaks). We record RR intervals in milliseconds through ECG channel . Then by 
using the specific software algorithms the recorded ECG signal is processed and 
the regular heart beat pattern can be determined from the wave patterns recorded. 
 
 R-R interval: This is the duration of time interval between two subsequent 
R wave peaks. The duration of the RR interval reflects the influence of  
sympathetic and parasympathetic activity. If a particular RR interval is longer 
than preceding one, it indicates a  increase in vagal tone compared to the 
sympathetic tone during that period of interval. Similarly increase in sympathetic 
activity or decrease in parasympathetic activity is reflected as reduced RR 
interval.(Philip A. Low 1997).RR interval is usually expressed in seconds or  
milliseconds. Among the limb leads, it is the lead II ECG recording of   R-R 
interval that is more specific. 
 
TIME DOMAIN METHODS  
 The time domain methods are simplest to perform since they are applied 
straight to the series of successive RR interval values. 
 
 The variables that can be recorded by this continuous ECG record includes 
SDNN, SDANN,RMSSD,SDNN INDEX,SDSD,NN50,pNN50. 
  
52 
 
TABLE:5 Frequency domain and Time domain methods 
 
 
 
FREQUENCY DOMAINS 
VLF (0-0.04Hz) 
 This indicates sympathetic activity, renin angiotensin system activity, 
baroreflex activity and regulation of temperature.  
 
 Not relevant in 5min ECG recordings since this parameter does not have 
coherent properties and is affected by  baseline algorithms.  
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LF power (0.04-0.15Hz) 
 LF shows blood pressure maintenance of the sympathetic system by means 
of baroreflex mechanism.  
 
 This is used as an useful indicator for  sympathetic than parasympathetic 
activity.  Minimum of 2 minutes ECG recording is needed. 
 
HF power (0.15-0.4Hz):  
 HF power indicates parasympathetic activity mainly like gas exchange 
efficiency and Respiratory sinus arrthymia.  
 
 Just 1 minute ECG recording is enough. 
 
ULF- less than 0.003 Hz 
 This is used for analyzing long term recordings for a period of 24 hr. 
clinical significance of this parameter is not  defined clearly. 
 
Normalization of units:  
 LF (n.u) and HF (n.u) are the normalization of the powers which gives near 
100% values of the sympathetic and parsympathetic events. They are calculated as 
follows:  
 
LF (n.u) = LF power/(LF + HF power) or LF power / TP-VLF  
HF ( n.u) = HF power/ (LF+HF power) or HF power / TP-VLF  
Total power = LF+HF power 
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LF/HF ratio:  
 This has been used as an index of global sympatho-vagal balance. 
Measurement of LF, HF are done  in normalized units.(89) 
 
 The distribution of LF and HF are not fixed but vary in relation to 
sympathovagal balance of the autonomic nervous system. 
 
 The standard deviation of the mean RR interval is used to determine  
cardiovascular autonomic function. The standard deviation gives a statistical 
measure of the variability  of the RR intervals around the average heart rate.  
Depending on the number of observations (RR intervals) and the mean Heart rate, 
the results are determined.(54) 
 
 It is stated that the actual difference between adjacent RR intervals is more 
sensitive than the standard deviation to short term fluctuations in heart rate. 
RMSSD is  the square root  of the squares of the differences between adjacent  
R-R  interval.(55) 
 
 In our study we are using both Time domain and Frequency domain 
methods of resting heart rate variability analysis to determine the sympathovagal 
balance in Iron deficiency anemia female subjects. 
 
SERUM FERRITIN AND HRV 
 Ferritin is arranged in the form of a hollow sphere and the central cavity of 
this sphere stores around 4500 iron atoms.(56)Studies by microdiffraction 
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procedures shows Iron cores have a hexagonal structure.(57) Light microscopic 
finding shows hemosiderin as yellow coloured iron containing pigment inside the 
cell. When viewed under electron microscope, hemosiderin shows clusters of 
ferritin enclosed within membrane.(58)The ferritin present within lysosomes gets 
converted into hemosiderin by partial degradation of protein shell by action of 
lysosomal enzymes.(59)But ferritin which is degraded within cytoplasm causes 
complete release of iron.(60) 
 
 The ferritin present in cytoplasm of the early precursors of RBCS is used 
for the synthesis of hemoglobin, but the ferritin in the form of clusters in mature 
erythroblasts represents the storage form of iron.(61) 
 
 Within  120 days of life span ,a single red blood cell  loses 15 to 20 percent 
of its hemoglobin concentration.(62)The mechanism by which RBC loses its 
hemoglobin without an inordinate amount of cell membrane losing with it always 
remains as one of the under explained fact of haemotology.(63) 
 
 Peripheral smear shows leucopenia in some patients.(64) Thromocytosis is 
seen in 50 to 75 percent of the cases due to blood loss.(65,66) Reticulocytes will be 
mildly increased.(67-70) 
 
 In Iron deficiency anemia, Iron stores are depleted before the red cell mass 
is reduced. Estimation of iron stores is considered as a sensitive and a reliable one 
for differentiating IDA and other anemias .Moreover evaluating the Iron stores in 
marrow macrophages is the gold standard one for diagnosing IDA.(71,72)But this 
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method is not feasible. So we prefer serum ferritin for diagnosing Iron deficiency 
anemia.     
 
 Serum ferritin concentration also increases in inflammatory disorders like 
rheumatoid arthritis, chronic renal disease and malignancies.(73)and  these 
disorders  has to be ruled out. 
 
 Postural tachycardia syndrome(POTS) is due to underlying autonomic 
dysfunction. Dysfunction of sympathetic activity causes this syndrome. Studies 
showed female patients with lower level of ferritin, develop postural tachycardia 
syndrome(POTS)  more than the females with normal serum ferritin.(74) 
 
 Only very few studies have focussed the relationship between serum 
ferritin and HRV parameters .Our study has been aimed to correlate the HRV 
parameters with the serum ferritin levels of  iron deficient individuals.  
 
  
Aim and Objectives 
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AIM AND OBJECTIVES 
 
AIM  
 To study the association between HRV parameters and Iron deficiency 
anemia in female population and to correlate with serum ferritin levels. 
 
OBJECTIVES  
A. PRIMARY  
 To compare the heart rate variability among female patients with   iron 
deficiency anemia and normal female population. 
 
B. SECONDARY. 
 To estimate the serum ferritin among female  patients with  iron deficiency 
anemia and normal female  population . 
 To correlate the heart rate variability with serum ferritin levels  of female  
patients with iron deficiency anemia. 
  
  
Materials and Methods 
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MATERIALS AND METHODS 
 
STUDY DESIGN 
 The study was conducted as a cross sectional  study comparing the heart 
rate variability between females with iron deficiency anemia and normal female 
population and correlation of serum ferritin levels with HRV parameters by 
Pearson’s rank correlation. 
 
STUDY CENTRE 
 The study was conducted in Institute of Physiology & Experimental 
Medicine, Department of hematology  and Institute of Internal Medicine, Madras 
Medical College, Chennai. 
 
STUDY DURATION 
 The study was carried out from April 2017 to March 2018.  
 
STUDY POPULATION 
 The study population comprised of females with and without iron 
deficiency anemia visiting RGGGH, Chennai. 
 
Inclusion Criteria 
1. Females in 18 – 45 years age group with Hemoglobin <12 gm%, serum 
ferritin<12ng/ml, Complete Blood Count parameters(Mean corpuscular 
volume,Mean corpuscular haemoglobin,Mean corpuscular haemoglobin 
concentration ,Red cell distribution width)showing lower  values than the 
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normal range.(MCV–80–100femtolitres,MCH-27–32picograms,MCHC–32-
36g/dl,RDW-11.5-14.5%), Peripheral smear- Microcytic hypochromic anemia. 
 
Exclusion Criteria 
1. Other forms of anemia 
2. Heart diseases –(structural) 
3. Diabetes mellitus, Hypertension 
4. Renal failure 
5. Hypo/Hyperthyroidism 
6. Pregnancy 
7. Chronic infections 
8. Chronic inflammations 
9. Exposure to radiation 
10. Drugs intake 
11. Autoimmume disorders 
12. Malignancy 
 
Sample Size 
Calculated sample size: 40 individuals in each group 
Sample size is calculated using the formula:    
(Z+ Zβ) 2 * 2 * σ2 
d2 
Where, Z = two tailed deviate for 95% confidence level = 1.96,  
 Zβ = two tailed deviate for 80% power of the study = 0.84 
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 σ = standard deviation of HRQOL scores of the total population  
 d = difference in mean HRQOL scores between two populations  
 
Data Collection and Methods 
 The study was started  after obtaining prior permission from the Director, 
Institute of Internal Medicine and the Director, Institute of Physiology & 
Experimental Medicine and The Dean, Madras Medical College and with  
approval of Institute Ethical Committee. (Annexure) 
 
 Each participant was given a brief introduction about the study and 
informed consent was obtained from all participants after explaining the 
objectives and procedures in detail. 
 
 After this the participants were subjected to the following set of 
investigations. 
 
1. Serum ferritin levels 
2. Complete blood count(CBC),peripheral smear(PS) 
3. Heart rate variability analysis 
 
Sample collection 
 Under universal sterile precautions 5 ml of venous blood sample was 
collected for estimation of serum ferritin, CBC,PS. Serum sample is centrifuged 
within 30 minutes of collection at 3000 rpm for 10 secs to separate the serum. 
Separation of  serum sample was done in biochemistry  laboratory at Rajiv 
Gandhi government hospital . The serum samples were stored at -20°C in a well 
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maintained deep freezer. 
 
 When adequate samples were collected serum ferritin assay was done by 
chemiluminescent immunoassay method. CBC and PS were done by fully 
automated analyser in the clinical pathology department at Rajiv Gandhi 
government hospital . 
 
ESTIMATION OF SERUM FERRITIN 
 Serum samples stored in  separate Eppendrof tubes were analysed by 
Chemiluminescent immunoassay method.(CLIA) 
 
Principle of the test: 
 This is a calorimetric method which  depends upon enzymatic reaction. 
The substrate used undergoes oxidative reaction and produces intermediate 
products. These  intermediates are acted upon by peroxidase enzymes resulting in 
the formation of a coloured dye. The colour intensity of the dye is directly 
proportional to the concentration of ferritin in the sample.  
 
Assay procedure: 
 Before  loading the samples,  the automated Cobas analyser calibration was 
done. Then the samples were loaded in the analyser and the test to be done is 
chosen in the computer. The analyser completes the test and data can be retrieved 
from the  computer. 
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Normal levels according to this assay are  
 Serum ferritin  normal range-12-291ng/ml. 
\ 
ANALYSIS OF HRV 
 Heart rate variability of the selected subjects was recorded and was 
analysed using the Medicaid Physiopac 8 channel HRV recorder. This instrument 
is commonly   used for research purpose and this  has an in built software for 
analysis of the recorded data. 
 
Procedure 
Instructions to the subject: 
 After explaining  to  the subject about the procedure to be done and 
purpose of recording the HRV with its uses  in understandable language consent 
was obtained. 
 
A convenient date was fixed up for the procedure. 
 
The following  instructions were given to the participants. 
 To have a good sleep the day before the recording 
 To have breakfast 2 hrs prior to the test. 
 To avoid Caffiene, Nicotine and Alcohol containing drinks 2 hrs before the 
test. 
 To be dressed up in comfortable and loose clothing . 
 To remove any accessories and jewellery that  interferes during the 
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recording 
 To come  with an attender.  
 To empty bladder just before the starting of the test. 
 To switch off mobile phones. 
 The subject should be relaxed without any anxiety 
 
 Recording was ideally done in the morning hours between 10 am-12 noon. 
The room should be made as quiet as possible and the temperature was 
maintained at an optimum level of 25-28°C in a subdued lighting and should be 
sound proofed. Before starting the test all the maneuvers involved were  explained 
to reduce the anxiety and to get better cooperation. All the vital parameters like 
pulse rate, blood pressure, temperature and respiratory rate were recorded. 
 
 Then the participant was made to rest quietly in the supine position with 
eyes open and to relax for about 10- 15 mins before connecting the electrodes. 
 
Electrode placement: 
 Limb leads were used  for this test. The area where the leads are to be 
placed was well cleaned with spirit and the specialized leads were attached to all 
the four extremities. The limb leads are then connected to the ECG recorder 
attached to the Medicaid 8 channel Physiopac. The lead II is chosen for recording  
the parameters . Then  ECG is recorded at this resting state for 5 mins. The 
recordings are saved for analysis. Short term HRV analysis was done .After 
screening the artifact  the results were edited and fed to HRV analysis soft ware. 
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 The analogue for the digital conversion of resting ECG signal was done by 
using AD converter with the sampling frequency rate of 1024/sec. After this, 
power spectral analysis of the converted ECG signal was done using Fast fourier 
Transformation. 
 
 Mean RR, Mean HR,  SDNN, RMSSD, Low Frequency, High Frequency, 
LF/HF ratio, were estimated. 
 
STATISTICAL ANALYSIS 
 The data obtained from the above  methods were statistically analysed 
using SPSS software version 21 . The correlation between individual parameters 
in the study were analysed by Pearson’s  rank correlation .The mean and standard 
deviation of the variables were determined for case and control groups. Unpaired t 
test was employed for statistical analysis as the test of significance at 95% 
confidence interval. * P value < 0.05 was considered as significant. ** P value < 
0.01 was considered as highly significant. ***P value < 0.001 was considered as 
very highly significant. 
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RESULTS 
 
 In our study, 40 patients who were clinically diagnosed of Iron deficiency 
anemia were tested for assessment of their autonomic functions by using the Heart 
rate variability analysis and the estimated values are compared with that of 40 
clinically healthy individuals. 
 
 The mean age of the study group was 32.1±7.7, where  the control group 
were of mean age  of 29.18±7.32 and the female Patients with Iron deficiency 
anemia were of mean age of 35.1 ±6.98  as shown in Table 6, Fig.1a 
 
 The mean value of weight for the control group and the female  patients 
with Iron deficiency anemia were 49.7 ±11.1 and 164.12 ±11.7 respectively as 
shown in Table 6. 
 
 The mean value of BMI for the control group and the female  patients with 
Iron deficiency anemia were 21.4 ±2.5 and 22.3 ±1.9 respectively as shown in 
Table 6. 
 
 The mean value of Hemoglobin for the control group and the female 
patients with Iron deficiency anemia were 12.76 ±0.64 and 9.46 ±1.49 respectively 
as shown in Table 6,Fig1b 
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Table.6: Comparison of socio-demograpic details between the control group 
and patients with Iron deficiency anemia. 
Variables Control group , n=40 IDA patients, n=40 
 Mean SD Mean SD 
Age(years) 29.18 7.32 35.1 6.98 
Height(cms) 161.32 12.5 *164.12 11.7 
Weight(Kgs) 49.7 11.1 *51.4 9.8 
BMI 21.4 2.5 *22.3 1.9 
Hemoglobin(gms/dl) 12.76 0.64 *9.46 1.49 
*p value<0.05 is considered as statistically significant. IDA = patients with Iron 
Deficiency Anemia. BMI= Body Mass Index. 
 
(i) Estimation of Resting heart rate, systolic blood pressure and the diastolic 
blood pressure among the study group: 
 The blood pressure parameters, systolic and diastolic blood pressure as well 
as the heart rate at the resting levels were compared between the control group and 
female patients with Iron deficiency anemia as described in Table.7, Fig.2a,2b,2c. 
 
 A very highly significant  increase in mean heart rate(85.38±5.8,   p<0.001)  
is observed in female  patients with iron deficiency anemia when compared to that 
of the control group(78.28±5.26) as shown in Table.7,Fig.2a. This could be mainly 
due  to sympathetic overactivity in  patients with Iron deficiency anaemia.  
 
 The resting systolic blood pressure in female patients with Iron deficiency 
anemia showed a significantly lower value(103.55±9.47 , p<0.001) compared to 
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that of the control group(112.95±9.40) as shown in Table.7,Fig.2b. The  decrease 
in systolic blood pressure could  be due to anemia.  
 
 The resting diastolic blood pressure in female patients with Iron deficiency 
anemia showed a significantly lower value( 69.60±6.87  , p<0.014) compared to 
that of the control group(73.10±5.43) as shown in Table.7,Fig.2c. Diastolic blood 
pressure reflects the peripheral resistance, here in this study the decrease in DBP  
indicates the decrease in afterload due to adaptability changes that occurs in 
anemia. 
 
Table.7:Comparison of the Resting heart rate, Resting systolic blood pressure 
and Resting diastolic blood pressure between the control group and female 
patients with iron deficiency anemia 
Variables 
Control group, n=40 IDA patients, n=40 
Mean SD Mean SD 
Resting Heart rate 
(beats/min) 78.28 5.26 ***85.38 5.83 
Resting 
SBP(mm/Hg) 112.95 9.4 ***103.55 9.47 
Resting DBP 
(mm/Hg) 73.1 5.43 *69.6 6.87 
*p<0.05 which is considered as statistically significant. ** P value < 0.01 was 
considered as highly significant. SBP=systolic blood pressure      ,DBP=diastolic 
blood pressure  . 
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(ii) Estimation of serum ferritin levels among the study group: 
 Serum ferritin reflects the iron in the storage pool.  The serum ferritin levels 
was significantly lesser in female patients with iron deficiency anemia( 8.70  
±2.11 ,p<0.001) compared to  that of the control group( 121.85   ± 65.40  ) as 
shown in Table.8,Fig.3.Decrease in serum ferritin levels indicates iron stores are 
depleted in iron deficiency anemia. 
 
Table.8: Comparison of the serum ferritin levels between the control group 
and female patients with iron deficiency anemia: 
Variable Study group N Mean SD 
Serum Ferritin 
(ng/ml) 
Control 40 121.85 65.40 
IDA 40 ***8.70 2.11 
*p<0.05 which is considered as statistically significant.  ** P value < 0.01 was 
considered as highly significant. IDA = patients with Iron Deficiency anemia. 
 
(iii) Estimation of Mean Heart Rate(beats/min) among the study group: 
 The mean Heart rate in female patients with Iron deficiency anemia was 
found to be significantly increased ( 87.23   ±7.63    , p<0.001) when compared to 
that of the controls(77.20±6.19) as shown in Table.9,Fig. 4. 
 
 Increased mean heart rate of HRV analysis  in Iron deficiency anemia 
indicates the possibility of sympathetic overactivity. 
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Table.9: Comparison of the mean Heart rate(beats/min)between the control 
group and female patients with iron deficiency anemia: 
Variable Study group N Mean SD 
Mean Heart 
Rate  
(beats/min) 
Control 40 77.20 6.19 
IDA 
 40 ***87.23 7.63 
*p<0.05 which is considered as statistically significant.  ** P value < 0.01 was 
considered as highly significant. IDA = patients with Iron Deficiency anemia 
 
(iv) Estimation of Mean RR interval (ms) among the study group: 
 The mean RR interval in female patients with Iron deficiency anemia was 
found to be significantly decreased ( 704.80  ±115.69 , p<0.001) when compared 
to that of the controls (804.68±84.46) as shown in Table.10,Fig.5. 
 
 Mean RR interval(ms) of HRV analysis reflects interbeat intervals. 
Decreased  mean RR interval in Iron deficiency anemia indicates  the possibility 
of reduced vagal tone. 
 
Table.10: Comparison of the Mean RR interval (ms )between the control 
group and female patients with iron deficiency anemia: 
Variable Study group n Mean SD 
Mean RR 
interval (ms) 
Control 40 804.68 84.46 
IDA 
 40 ** *704.80 115.69 
*p<0.05 which is considered as statistically significant. ** P value < 0.01 was 
considered as highly significant.  IDA = patients with Iron Deficiency anemia. 
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 (v) Estimation of mean SDNN(ms) in HRV among the study group: 
The mean  SDNN in female patients with Iron deficiency anemia was found to be 
significantly decreased ( 39.39   ±8.37, p<0.012) when compared to that of the 
controls(44.14±8.14  ) as shown in Table.11,Fig.6 
 
 Mean SDNN of HRV analysis reflects  parasympathetic function. 
Decreased  mean SDNN in patients with Iron deficiency anemia  indicates the 
possibility of reduced parasympathetic activity. 
 
Table.11:Comparison of the Mean SDNN (ms)between the control group and 
female patients with iron deficiency anemia: 
Variable Study group N Mean SD 
Mean SDNN 
(ms) 
Control 40 44.14 8.14 
IDA 40 **39.39 8.37 
*p<0.05 which is considered as statistically significant.  ** P value < 0.01 was 
considered as highly significant. IDA = patients with Iron Deficiency anemia. 
 
(vi) Estimation of mean RMSSD (ms)in HRV among the study group: 
 The mean RMSSD in female  patients with Iron deficiency anemia was 
found to be significantly decreased ( 33.43  ±6.12, p<0.001) when compared to 
that of the controls( 39.22  ±6.37  ) as shown in Table12,Fig.7. 
 
 Mean RMSSD of HRV analysis reflects parasympathetic function. 
Decreased mean RMSSD in patients with Iron deficiency anemia indicates the 
possibility of reduced parasympathetic  tone. 
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Table.12: Comparison of the mean RMSSD (ms)between the control group 
and female patients with iron deficiency anemia: 
Variable Study group N Mean SD 
Mean RMSSD 
(ms) 
Control 40 39.22 6.37 
IDA 40 ***33.43 6.12 
*p<0.05 which is considered as statistically significant. ** P value < 0.01 was 
considered as highly significant.  IDA = patients with Iron Deficiency anemia. 
 
(vii) Estimation of mean LF value(normalized unit) in HRV among the study 
group: 
 The mean LF  in female  patients with Iron deficiency anemia was found to 
be significantly increased (56.49  ±11.63 ,  p<0.001) when compared to that of the 
controls(44.8  ±  8.28  ) as shown in Table.13,Fig.8. 
 
 Mean LF of HRV analysis reflects sympathetic function. Increased  mean 
LF  in patients with Iron deficiency anemia indicates the possibility of sympathetic 
over activity. 
Table.13: Comparison of the mean LF in HRV between the control group 
and female patients with iron deficiency anemia: 
Variable Study group N Mean SD 
Mean LF(nu) 
Control 40 44.8 8.28 
IDA 40 ***56.49 11.63 
*p<0.05 which is considered as statistically significant. ** P value < 0.01 was 
considered as highly significant.  IDA = patients with Iron Deficiency anemia. 
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(viii) Estimation of mean HF value(normalized unit)in HRV among the study 
group: 
 The mean HF  in female patients with Iron deficiency anemia was found to 
be significantly decreased (42.46  ±12.53,   p<0.001) when compared to that of the 
controls(54.92  ±  7.97)    as shown in Table.14.Fig.9 
 
 Mean HF of HRV analysis reflects  parasympathetic function. Decreased  
mean HF  in patients with Iron deficiency anemia indicates the possibility of 
reduced parasympathetic tone. 
 
Table.14: Comparison of the mean HF in HRV between the control group 
and female patients with iron deficiency anemia: 
Variable Study group N Mean SD 
Mean HF(nu) 
Control 40 54.92 7.97 
IDA 40 * * * 42.46 12.53 
*p<0.05 which is considered as statistically significant. ** P value < 0.01 was 
considered as highly significant.  IDA = patients with Iron Deficiency anemia. 
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(ix) Estimation of mean LF/HF ratio in HRV among the study group: 
 The mean LF/HF ratio  in female patients with Iron deficiency anemia was 
found to be significantly increased (1.57 ±0.94,  p<0.001) when compared to that 
of the controls(0.86 ±0.33) as shown in Table.15,Fig.10 
 
 Mean LF/HF ratio  of HRV analysis reflects  sympathovagal balance. 
Increased mean LF/HF ratio  in patients with Iron deficiency anemia indicates 
sympathetic overactivity. 
 
Table.15: Comparison of the mean LF/HF ratio in HRV between the control 
group and female  patients with iron deficiency anemia: 
 
Variable Study group N Mean SD 
Mean LF/HF 
ratio 
Control 40 0.86 0.33 
IDA 40 ** *1.57 0.94 
*p<0.05 which is considered as statistically significant. ** P value < 0.01 was 
considered as highly significant.  IDA = patients with Iron Deficiency anemia. 
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Table.16: Correlation between the Serum ferritin levels and variables of  
HRV analysis 
Dependent 
variable Variables R
2 value 
95% C.I.  
Lower Upper p 
 
 
 
 
 
 
 
Serum 
Ferritin 
levels 
Mean Heart 
rate per min -0.446 -0.43 -0.69 <0.001 
MeanRR(ms) 0.342 0.31 0.56 <0.001 
SDNN(ms) 0.277 0.24 0.48 0.01 
RMSSD(ms) 0.276 0.24 0.48 0.01 
LFnu -0.467 -0.45 -0.72 <0.001 
HFnu 0.471 0.46 0.72 <0.001 
LF/HFratio -0.376 -0.35 -0.61 <0.001 
 
A highly significant negative correlation(p<0.001) was found between the serum 
ferritin levels and the mean heart rate, mean LF and mean LF/HF ratio. A 
significant positive correlation(p<0.01) was observed between the serum ferritin 
levels and the mean RR, mean SDNN, RMSSD and mean HF.  
  
Fig. 1a:Comparison of age between  female patients with Iron deficiency 
anemia and the control group 
 
 
Fig. 1b: Comparison of hemoglobin between  female patients with Iron 
deficiency anemia and the control group. 
 
 
 Fig. 2a: Comparison of the Resting heart rate between female patients with 
iron deficiency anemia and the control group 
 
 
 
Fig.2b: Comparison of the Resting systolic blood pressure  between female 
patients with iron deficiency anemia and the control group 
 
 
 
 Fig. 2c: Comparison of the  Resting diastolic blood pressure between  female 
patients with iron deficiency anemia and the control group 
 
 
 
Fig.3 Comparison of the serum ferritin levels between female patients with 
iron deficiency anemia and the control group: 
 
 
 Fig.4:Comparison of the mean Heart rate(beats/min)between female patients 
with iron deficiency anemia and the control group 
 
 
 
Fig.5: Comparison of the Mean RR interval (ms)between female patients with 
iron deficiency anemia and the control group 
 
 
 
 Fig.6:Comparison of the Mean SDNN (ms)between female patients with iron 
deficiency anemia and the control group 
 
 
 
Fig.7:Comparison of the mean RMSSD (ms)between female  patients with 
iron deficiency anemia and the control group 
 
 
 Fig.8:Comparison of the mean LF(nu) between female patients with iron 
deficiency anemia and the  control group 
 
 
 
Fig.9:Comparison of the mean HF(nu) between female  patients with iron 
deficiency anemia and the control group 
 
 
  
 
 
 
 
 
Fig. 10:Comparison of the mean LF/HF ratio between female  patients with 
iron deficiency anemia and the control group 
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DISCUSSION 
 
 Iron deficiency anemia has been found to be associated with increased 
cardiovascular morbidity and mortality. It affects cardiac function. Decreased 
Heart rate variability(HRV) has been found to be associated with increased 
mortality and morbidity in several heart disorders like myocardial infarction, 
cardiomyopathy, congestive heart failure and chronic mitral regurgitation.(75-78) 
 
 The physiological change  which occurs in anemia is a compensatory 
increase in  cardiac output, preload ,heart rate, stroke volume associated  with a 
decrease in the afterload. This increase in  sympathetic activity causes palpitation , 
tachycardia in iron deficiency anemic patients (79)  and Progression of iron 
deficiency anemia  results in cardiomyopathy. 
 
 Mechanism  behind this pathogenesis has not been fully understood so far. 
But there are many advancing research trails related to this  that have led to the 
formation of new hypothesis. 
 
 This study was primarily aimed to analyze the cardiac autonomic function 
in Iron deficiency anemia by doing Heart rate variability analysis. Forty  iron 
deficiency female subjects and forty  age and gender  matched normal controls 
were included in our study. 
 
 The study group  were selected between the age group of 18 to 45 years 
females. 
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Comparison of socio-demograpic details between the control group and 
female patients with Iron deficiency anemia 
 The mean age of the control group was 35.10 ± 6.98 and the mean age of  
female patients with Iron deficiency anemia was 29.18 ± 7.32. The difference  
was not significant  in relation to age. This was in consistent  with the earlier 
studies. The mean height of the control group was 161.32±12.5 and the mean 
height of female patients with  Iron deficiency anemia was 164.12 ±11.7.The 
mean weight of the control group was 49.7±11.1 and mean weight of female 
patients with Iron deficiency anemia was 51.4±9.8.The mean BMI of the control 
group was 21.4±2.5 and  the mean BMI of female patients with Iron deficiency 
anemia was 22.3±1.9 .The difference was found to be significant  in relation to 
height, weight and BMI . 
 
Comparison of Resting heart rate between the control group and female 
patients with iron deficiency anemia 
 
 The mean resting heart rate of control group was 78.28 ± 5.26    and  the 
mean resting heart rate of   female patients with Iron deficiency anemia  was 
85.38±5.83. An elevated level of sympathetic activity and decreased 
parasympathetic tone   was seen  in iron deficiency anemia patients  as per results 
of the study done by Tuncer et al (19). Our study showed there was increase in the 
mean heart rate in female patients with Iron deficiency anemia . The Possible 
reason for this could be the increase in the sympathetic activity  of the iron 
deficiency anemia patients. 
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Comparison  of Resting systolic blood pressure between the control  group 
and female patients with  iron deficiency anemia 
 
 The mean resting systolic blood pressure  in control group  was 112.95± 
9.40 and  the mean resting systolic blood pressure in female patients with  iron 
deficiency anemia was 103.55±9.47 . Our study showed decreased systolic blood 
pressure in  iron deficiency anemia female patients when compared to controls. 
Anemia leads to many adverse effects and this is observed in many pathological 
conditions like end stage renal failure and myocardial infarction. But how 
presence of anemia progresses to heart failure is being evaluated recently 
only.(90,91,92)Studies show anemia  patients  with systolic dysfunction when not 
treated can  progress to  heart failure .(90,91,93-96) 
 
Comparison of  Resting diastolic blood pressure  between the control  group 
and female patients with iron deficiency anemia 
 
 The mean resting diastolic blood pressure in control group was 73.10 ±5.43 
and the mean resting diastolic blood pressure in female patients with Iron 
deficiency anemia was 69.60 ±6.87 .Our study showed  decreased diastolic   blood 
pressure in  cases when compared to controls .This was consistent with the 
findings observed in the study done by Deepu nair et al.(97) 
 
 There are many explanations regarding mechanisms concerned with 
relationship between anemia and diastolic dysfunction. Presence of anemia for 
prolonged period results in adaptation and this causes increase in heart rate 
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,cardiac index ,stroke volume and plasma volume.(98,99) All these changes of 
increased sympathetic activity and ionotropic activity leads to additional stress on 
myocardium.(100) 
 
Comparison of Haemoglobin between the control  group and female patients 
with  iron deficiency anemia 
 
 The mean haemoglobin in  control group was12.76 ±0.64 and the mean 
haemoglobin in female patients with Iron deficiency anemia was 9.46±1.49  .Our 
study showed that  there was decreased haemoglobin in female patients with Iron 
deficiency anemia when compared to controls. The hormonal, metabolic changes 
due to anemia also cause direct myocardial damage and also through salt, water 
retention indirectly exerts strain on the myocardium. This forms the basis of the 
hypothesis that anemic adaptability causes ventricular remodeling, diastolic 
dysfunction and systolic dysfunction. 
 
Comparison of Serum ferritin between the control  group and female 
patients with iron deficiency anemia 
 
 The mean serum ferritin in control group was 121.85±65.40 and the mean 
serum ferritin in female patients with Iron deficiency anemia was 8.70±2.11 
Female patients with Iron deficiency anemia showed  decreased serum ferritin 
levels when compared to controls. This is due to the decrease in the  iron stores  in 
iron deficiency anemia.  
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 Studies show that  normal ferritin can show variations related to age and 
sex. Serum ferritin level in women shows lower values until menopause and 
values shows increase thereafter. (104) 
 
Resting heart rate variability 
 Heart Rate Variability (HRV) analysis is considered as one of   the 
effective, non- invasive tool to assess the  function of the Autonomic nervous 
system. There occurs  an increased risk of adverse cardiac events when there is 
alteration in  resting HRV. Analysis of the resting heart rate variability by doing  5 
minutes ECG recording using the HRV analysis  among the study groups showed 
the following results.  
 
Time domain measures 
 Mean HR, Mean RR, SDNN, RMSSD were the variables taken for 
analysis in our study as prescribed by the Task force. Our findings showed 
decreased HRV  in female patients with Iron deficiency anemia. Decreased HRV  
suggests  either increased sympathetic tone or decreased parasympathetic tone. 
 
 The Mean HR was significantly increased in  female patients with Iron 
deficiency anemia   (87.23±7.63) when compared to  controls(77.20±6.19) . This 
shows tacycardia  in the Iron deficieny anemia patients. This finding was 
consistent with the findings  observed in the studies done by Tuncer et al  . 
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 The Mean RR among the study groups were measured which shows 
decreased mean RR interval(704.80±115.69) in the female patients with Iron 
deficieny anemia  when compared with  controls(804.68±84.46). Similar  findings 
were also observed in studies done by Yokusoglu et al. 
 
 In our study female patients with Iron deficiency anemia  showed 
decreased mean values of SDNN(39.39±8.14) and RMSSD(33.43±6.12) when 
compared with the normal controls SDNN(44.14±8.14) and RMSSD(39.22±6.37). 
This was also consistent with  the findings of Farhana rahman et al.  Similar 
finding were also observed  in  studies done  by Yokusoglu et al . 
 
 Results from studies done by shetty KP et al, and Tuncer et al   showed 
there is no difference in the HRV parameters in iron deficiency anemia patients 
and normal subjects except mean HR. Lufti et al reported no significant 
difference in  values of SDNN and RMSSD  in Iron deficiency anemia and 
healthy controls. 
 
 But our study results show decreased SDNN and RMSSD which indicates 
that parasympathetic activity is decreased in iron deficiency anemia  when 
compared with normal subjects. 
 
 The SDNN, RMSSD were considered as sensitive indicators of 
parasympathetic function and thereby a  significant low value indicates reduced 
vagal activity in   Iron deficiency anemia patients. 
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Frequency Domain Measures: 
LFnu, HFnu and LF/HF ratio were  the variables taken for analysis in our study 
as prescribed by the Task force. 
 
 A significant variation was observed in the frequency domain variables 
among the study groups. The LF values in  normalized units(nu) which is an 
indicator of sympathetic tone was significantly higher in female patients  with 
Iron deficiency anemia (56.49±11.63) when compared with normal 
controls.(44.81±8.28). 
 
 The HF values in normalized units(nu) which is an indicator of 
parasympathetic tone was found to be significantly lower in female patients with 
Iron deficiency anemia(42.46±12.53) when compared with the 
control.(54.92±7.97) 
 
 As the HF power indicates the vagal activity ,our study finding suggest that 
there is decreased parasympathetic activity  in female patients with Iron 
deficiency anemia . Our study findings were consistent with findings of Lufti et 
al .His study showed VLF,LF,HF,TP was positively correlated with haemoglobin 
concentration. HRV parameters were found to be decreased. Study by  Gehlot 
pinkesh et al shows that there was no statistically significant relation between 
hemoglobin and HRV in anemia.(105) 
 
 LF/HF ratio was increased in  iron deficiency individuals(1.57±0.94) when 
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compared with the controls(0.86±0.33) due to sympathovagal imbalance. This  
ratio signifies the overall balance between sympathetic and parasympathetic 
system .In addition sympathetic stimulation enhances erythropoiesis. Studies of 
Biaggioni et al  supports this hypothesis .Sympathetic stimulation in anemia 
stimulates erythropoiesis .These  cases with autonomic dysfunction showed good 
response to erythropoietin therapy.(106) 
 
 Therefore  in our study it was found  that parasympathetic activity 
decreases and sympathetic activity increases in patients with iron deficiency 
anemia. 
 
 The possible reason is, in iron deficiency anemia due to decreased 
hemoglobin concentration the oxygen carrying capacity of blood is decreased  
which leads to hypoxia. This hypoxia  will be sensed through the carotid bodies 
which influences the cardiovascular centres  leading to increase in the sympathetic 
activity.(82)The mechanism causing carotid body activation is supposed to be 
either due to hypoxia related mitochondrial respiratory chain inhibition or due to 
potassium channel suppression that causes intracellular calcium accumulation.(83) 
 
 This type of anemic hypoxia stimulates the adrenergic nervous system. 
Stimulation of this leads to the cardiovascular response like tachycardia and 
increased cardiac output. These  changes will try to compensate the decrease in 
the oxygen content of the   blood. Moreover the activation of the adrenergic 
system  can be known by estimating the concentration  of  plasma and urine 
epinephrine(84),which is not done in our study. 
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 These patients have low basal parasympathetic outflow and as a 
compensatory mechanism  there is an increase in the heart rate.  So these changes 
in HRV has been taken as  a sensitive  indicator of health  deterioration due to 
autonomic changes.(85) 
 
 Hence HRV is used as early and better qualitative and quantitative method 
to detect the autonomic impairment. High HRV indicates well functioning of the 
autonomic nervous system and on the other hand  when HRV is reduced it acts as 
a risk indicator to know the adverse complications in the patients suffering from 
wide range of diseases.(86) 
 
 So in our study HRV has been used to know the cardiovascular mortality in 
female patients with Iron deficiency anemia. 
 
 There are studies which have reported that supplementation of iron can 
improve the dysregulated autonomic nervous system reflexes. (87) 
 
 So our study has been aimed to diagnose Heart rate variability by HRV 
analysis as  early as possible to avoid the morbidity and mortality due to 
cardiovascular changes by assessing the autonomic imbalance, So that by 
supplementing iron therapy it is possible to prevent the cardiovascular  
complications in these patients . 
 
Serum ferritin and HRV parameters correlation 
 Serum ferritin levels was correlated with Mean heart rate, Mean 
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RR,SDNN, RMSSD, LFnu,  HFnu, LF/HF ratio.  
 A highly significant negative correlation(p<0.001) was found between the 
serum ferritin levels and the mean heart rate, mean LF and mean LF/HF ratio. A 
significant positive correlation(p<0.01) was observed between the serum ferritin 
levels and the mean RR, mean SDNN, RMSSD and mean HF.  
 
 This finding was consistent with findings in the study done by Daniel 
wallman et al. This study showed decrease in serum ferritin that lead to the 
change in HRV parameters which reflected the autonomic dysfunction 
.Mechanism which was proposed was decreased iron stores initiated carotid body 
reflex(107) and this reflex activity increased due to decreased blood flow 
.Dysfunction of  sympathetic system affected  the  vascular tone.  These 
individuals are prone to  develop  syncope  when they stand from lying posture. 
 
LIMITATIONS OF THE STUDY  
 Our study has involved  a smaller sample size. It is necessary to  apply it to 
a general population  using larger sample size to get better outcome of the study. 
The duration of the disease and autonomic dysfunction was  not correlated in our 
study. 
 
 The study  has evaluated only the resting autonomic activity and not the 
response of the autonomic nervous system to various  external stimuli or lab 
stressors ,which is a drawback for the study.  
 
 One of the  mechanisms suggested for autonomic dysfunction   is elevated 
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circulating nor epinephrine levels and urine norepinephrine concentration . Hence 
our study need to be substantiated by measurements of the catecholamine 
 norepinephrine levels  which is not done in our study.  
 
 Moreover blood gas analysis was not done for anemic hypoxia. Serum 
ferritin assay has to be combined with other iron studies like total iron binding 
capacity, and transferrin saturation for better outcome,  because serum ferritin is  
also an acute phase reactant that shows elevated levels in inflammatory 
conditions. 
 
  
Conclusion 
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CONCLUSION 
 
 The sympathetic and parasympathetic activity and the  functional status of 
the heart were evaluated in  iron deficiency anemia female patients using Resting 
Heart rate variability. 
 
 This study concludes that there is an autonomic imbalance as evidenced by 
decrease in SDNN, RMSSD which were indicators of parasympathetic  and 
increase in LF power (nu) showing the sympathetic activity. The ratio between LF 
and HF was increased in iron deficiency anemia individuals   which showed 
sympathetic dominance of autonomic nervous system activity. So by using HRV 
analysis as a sensitive and non invasive tool ,treatment can be started at the 
earliest  and  thus we can prevent the complications in iron deficiency anemia 
.Serum ferritin is used as a marker  to diagnose iron store depletion at the earliest, 
so that treatment  modality can be planned effectively in order to prevent    the  
cardiovascular complications. 
 
  
Summary 
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SUMMARY 
 
 Iron deficiency anemia is a common nutritional disorder with female 
preponderance. It is associated with autonomic dysfunction and cardiovascular 
risks like hypertension, atherosclerosis, and arrhythmias. We aimed to evaluate 
the autonomic system activity by using Resting heart rate variability analysis in  
females with Iron deficiency anemia .Serum ferritin level was estimated which 
indicated the iron stores of the individual. 
 
 Forty  female Iron deficiency individuals in the age group of 18-45 years 
was taken as the case group and age matched healthy females were taken as 
controls. Both of them were subjected to Resting  HRV. 
 
 Analysis of the data obtained from the study, showed that  female patients 
with Iron deficiency anemia is associated with autonomic dysfunction in the form 
of increased sympathetic activity and decreased parasympathetic activity 
compared to the controls  and decrease in serum ferritin level was correlated with 
increased sympathetic activity. 
 
 The observations in this study suggests that there is sympathetic over 
activity with decreased parasympathetic activity in female patients with  Iron 
deficiency anemia  which is  responsible for the pathogenesis of cardiovascular 
changes . And improvement in HRV  has to be assessed by further follow up 
studies with implementation of iron and the potential cardiovascular risks  can be 
prevented by regular follow up of these individuals with these noninvasive tests. 
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Control
No.
AGE (yrs)
HEIGHT 
(mts)
WEIGHT 
(kg)
BMI
HR/MIN 
Resting
SBP 
Resting (mm Hg)
DBP
Resting (mm 
Hg)
HB(g%)
Serum
Ferritin (ng/ml)
Mean 
HR/min
Mean
RR(ms)
SDNN (ms) RMSSD (ms) LF (nu) HF (nu) LF/HF ratio
1 18 1.63 54 20.32 76 120 72 13.6 196.2 70 759 54.4 41.2 34.2 64.6 0.529
2 27 1.56 50 20.55 84 110 72 14 201.3 85 786 45.1 44.2 58.6 41.2 1.422
3 24 1.59 50 19.78 82 126 68 12.8 184.6 79 859 38.4 28.2 38.6 61.4 0.628
4 30 1.48 48 21.91 90 100 62 12.4 96 94 759 40.7 36.2 62.2 37.6 1.654
5 32 1.55 53 22.06 75 120 74 13.6 194.4 75 812 60.2 54.6 35.2 64.4 0.546
6 39 1.58 48 19.23 82 104 64 12.4 98.4 87 676 38.4 33.6 59.6 49.4 1.206
7 24 1.56 50 20.55 76 116 76 12.9 186.6 72 819 49.8 38.4 33.2 66.8 0.497
8 18 1.55 52 21.64 96 96 64 14.6 206 94 690 34.4 29.8 66.8 32.2 2.074
9 18 1.45 47 22.35 78 122 74 12.8 184 79 890 46.4 34.8 38.4 61.2 0.627
10 30 1.6 52 20.31 84 94 88 13.9 198.8 86 784 40.2 36.3 59.4 40.4 1.470
11 36 1.56 50 20.55 82 108 78 12.2 42.2 76 839 57.4 28.4 46.8 53.2 0.879
12 20 1.48 48 21.91 84 98 68 13.6 196 86 670 32.4 28.4 52.6 46.2 1.138
13 28 1.55 51 21.23 74 118 72 12.3 48.6 78 759 37.6 34.8 42.2 56.4 0.751
14 25 1.58 48 19.23 80 100 60 12.2 48 82 690 35.2 30.8 54.6 45.4 1.202
15 24 1.57 52 21.1 82 112 76 13.2 190.8 74 823 43.9 36.7 34.1 64.4 0.529
16 42 1.54 52 21.6 82 90 60 12.4 63 84 752 40.2 38.4 50.6 48.4 1.045
17 34 1.62 56 21.34 75 116 74 12.6 183.2 72 820 40.8 41.3 37.6 60.2 0.624
18 36 1.65 53 19.47 78 118 78 12.1 38.2 77 810 37.4 43 47.1 50.6 0.93
19 24 1.46 50 23.8 82 122 76 12.3 52.4 73 823 40.6 41.4 40.2 58.6 0.686
20 20 1.45 47 22.35 84 116 74 12.3 52 82 890 43.9 37.9 42.2 56.6 0.745
21 22 1.55 53 22.06 80 120 72 12.3 50.2 74 824 44.6 42.2 44.2 54.6 0.809
22 27 1.48 48 21.91 76 114 70 14.2 202 73 980 54.9 33.8 31.8 68.2 0.466
23 23 1.62 54 20.32 76 116 74 12.4 74.6 76 839 57.4 38.2 43.8 56.2 0.779
24 33 1.54 52 21.6 78 110 72 12.3 74 70 890 34.9 38.9 43.6 56.2 0.775
25 37 1.6 52 20.31 76 100 74 13.2 194.3 75 812 36.4 41.3 34.4 65.4 0.525
26 27 1.48 48 21.91 74 110 76 12.3 52.2 72 670 36.6 40.2 44.8 55.2 0.811
27 20 1.6 54 20.32 75 124 72 12.7 184.8 74 821 44.6 41.1 37.6 62.2 0.604
28 34 1.55 51 21.23 76 126 76 12.2 38.6 69 885 45.8 38.6 47.4 52.4 0.904
29 36 1.46 50 23.8 74 122 78 12.4 92.2 80 984 56.5 38.2 40.2 59.4 0.676
30 42 1.6 54 21 72 118 78 12.3 90.4 74 823 38.1 41.1 42.4 57.6 0.736
31 40 1.59 50 19.78 74 120 76 12.1 25.6 72 680 36.4 55.7 49.4 50.4 0.98
32 43 1.55 53 22.06 76 120 74 12.6 120 73 740 45.4 43 46.8 53.2 0.879
33 24 1.65 53 19.47 80 118 78 12.5 112 79 690 37.9 55.6 46.2 53.6 0.861
34 20 1.58 50 20.03 82 120 76 12.7 183.4 70 892 46.7 41.1 39.2 60.4 0.649
35 26 1.62 50 19.05 70 118 78 12.1 28.2 78 964 48.1 41.2 48.2 51.6 0.934
36 28 1.68 54 19.13 72 110 76 12.3 78.9 80 820 37.4 41.1 44.2 55.6 0.794
37 36 1.57 52 21.1 76 116 74 13.4 196.8 72 680 38.2 38.9 42.4 57.2 0.741
38 35 1.65 53 19.47 72 120 76 12.7 146 73 758 46.7 43.4 43.6 56.2 0.775
39 32 1.54 52 21.93 74 100 72 12.8 172.6 74 865 64.2 33.7 42.6 57.4 0.742
40 33 1.62 50 19.05 72 110 72 12.5 96.4 75 860 57.4 43.2 45.2 54.6 0.827
MASTER CHART - CONTROL
CASE
No.
AGE (yrs)
HEIGHT 
(mts)
WEIGHT 
(kg)
BMI
HR/MIN 
Resting
SBP 
Resting (mm Hg)
DBP
Resting (mm Hg)
HB (g%)
Serum
Ferritin (ng/ml)
Mean 
HR/min
Mean
RR (ms)
SDNN (ms) RMSSD (ms) LF (nu) HF (nu) LF/HF ratio
1 23 1.72 84 28.39 88 102 62 9.1 7.5 90 678 40.7 36.3 62.2 37.6 1.654
2 20 1.58 82 32.85 78 118 70 8.7 6.8 78 890 36.2 40.1 31.6 68.2 0.463
3 39 1.54 78 32.89 86 112 70 5.9 5.23 96 786 43.9 54.4 75.6 24.4 3.098
4 30 1.65 83 30.49 76 122 78 9.3 7.2 77 810 50.4 41.4 43.6 56.4 0.773
5 45 1.54 73 30.78 80 96 60 11.4 11.8 84 692 36.4 40.2 50.6 48.4 1.045
6 26 1.54 81 34.15 74 118 72 10.4 11 73 823 56.4 26.6 43.6 56.2 0.775
7 42 1.49 70 31.53 90 100 70 9.2 6.9 93 692 36.2 40.4 59.6 40.4 1.475
8 22 1.53 78 33.32 75 114 76 9.1 7 74 960 64.2 33.8 27.6 70.2 0.393
9 32 1.54 81 34.15 78 90 62 10.2 10.8 80 694 37.9 35.2 54.8 45.2 1.212
10 38 1.47 71 32.86 80 110 76 9.1 7.6 69 887 48.1 42 32.4 60.2 0.538
11 18 1.58 86 34.45 86 92 74 10 10.12 89 682 34.2 29.6 56.2 42.4 1.325
12 40 1.47 71 32.86 76 120 74 11 11.2 80 810 54.9 26.6 54.6 60.2 0.574
13 32 1.55 80 33.3 86 102 72 10.4 11 84 750 40.2 38.2 58.2 48.2 1.207
14 26 1.47 71 32.86 80 114 70 11.4 11 79 890 49.8 38.4 42.4 56.4 0.751
15 44 1.49 70 31.53 84 102 64 10.4 11.6 86 780 38.4 33.6 56.6 42.2 1.341
16 32 1.58 86 34.45 78 110 72 11.1 11.6 73 992 62.4 41.1 44.4 55.2 0.804
17 43 1.72 84 28.39 92 100 72 9.2 7 94 688 35.2 34.6 69.2 28.6 2.419
18 44 1.49 70 31.53 86 98 60 10 9.8 90 672 34.8 30.6 55.1 42.8 1.287
19 40 1.62 84 32.01 86 104 80 10.3 11.2 88 780 40.6 36.2 50.1 49.7 1.008
20 34 1.54 78 32.89 88 106 78 10.4 11.8 84 680 36.2 24.8 57.6 42.2 1.364
21 38 1.56 84 28 92 120 70 9.6 8.6 96 670 32.2 24.8 59.5 40.3 1.476
22 40 1.53 86 28.6 96 124 72 9.2 7.2 98 660 30.4 26.8 70.2 29.8 2.355
23 32 1.49 70 31.53 84 110 70 11.1 7 86 458 38.4 34.4 52.8 47.2 1.118
24 28 1.55 80 33.3 84 104 60 10 10.16 86 676 36.4 34.2 58.2 41.8 1.392
25 36 1.65 83 30.49 90 100 70 9.3 8.2 92 619 38.6 33.6 59.5 40.3 1.476
26 38 1.72 84 28.39 96 102 60 6.2 6.43 98 774 40.2 38.2 79.2 20.4 3.882
27 40 1.53 78 33.32 92 90 60 9.8 8.4 94 682 34.1 30.6 60.4 39.4 1.532
28 42 1.62 84 32.01 84 100 72 10.3 8.2 86 593 32.2 28.6 54.9 45.1 1.217
29 38 1.63 54 20.32 84 96 84 10 10.4 88 576 32.1 28.2 57.2 42.6 1.342
30 32 1.56 50 20.55 86 94 82 9.4 7.6 88 730 38.6 36.2 62.2 37.8 1.645
31 35 1.59 50 19.78 84 100 82 10.2 11 88 662 36.6 34.4 56.6 43.1 1.313
32 36 1.48 48 21.91 90 102 70 6.3 6.48 92 540 42.2 34.2 79.2 20.4 3.882
33 28 1.55 53 22.06 88 96 64 4.3 3.2 92 676 34.2 24.6 80.2 17.6 4.556
34 35 1.58 48 19.23 92 94 60 9.7 7.8 97 576 34.6 28.2 59.6 42.2 1.412
35 36 1.56 50 20.55 94 96 72 10.4 9.8 96 580 36.2 32.4 54.8 45.2 1.212
36 40 1.55 52 21.64 94 100 72 8.6 6.8 97 582 30.4 28.4 57.2 22.6 2.530
37 42 1.45 47 22.35 86 90 62 8.8 7 88 582 30.2 28.2 59.4 42.4 1.400
38 44 1.6 52 20.31 84 92 64 8.9 6.8 86 640 34.2 28.4 57.4 22.4 2.562
39 38 1.65 83 30.49 82 100 62 10 10.14 84 660 34.6 28.6 54.8 44.2 1.239
40 36 1.47 71 32.86 86 102 64 9.8 8.6 96 620 32.1 30.2 60.2 38.4 1.567
MASTER CHART - CASE
